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ABSTRACT
Jonathon O’Brien: Statistical Methods for Mass Spectrometry Proteomics Experiments
(Under the direction of Bahjat Qaqish)
DNA makes RNA makes proteins is the central dogma of molecular biology. While the
measurement of RNA has dominated the landscape of scientific inquiry for many years, often the
true outcome of interest is the final protein product. Microarray and RNAseq studies do not tell
researchers anything about what happens during and after translation. For this reason interest
in directly measuring the proteome has flourished. Unfortunately the direct analysis of proteins
often creates a complicated inferential situation. When scientists want to see the whole proteome
(or at least a large unknown sample of the proteome) mass spectrometry is often the most
powerful technology available. Mass spectrometers allow researchers to separate proteins from
complex samples and obtain information about the relative abundance of around 10,000 proteins
in a given experiment. However the analysis of mass spectrometry proteomics data involves a
complicated statistical inference problem. Inference is made on relative protein abundance by
examining protein fragments called peptides. This inference problem is complicated by the two
intrinsic statistical difficulties of proteomics; matched pairs and non-ignorable missingness, which
combine to create unexpected challenges for statisticians. Here I will discuss the complexities of
modeling mass spectrometry proteomics and provide new methods to improve both the accuracy
and depth of protein estimation. Beyond point estimation, great interest has developed in the
proteomics community regarding the clustering of high throughput data. Although the strange
nature of proteomics data likely causes unique problems for clustering algorithms, we found that
work needed to be done regarding the statistical interpretation of clustering before any special
cases could be considered. For this reason we have explored clustering from a statistical framework
and used this foundation to establish new measures of clustering performance. These indices
allow for the interpretation of a clustering problem in the commonly understood framework of
iii
sensitivity and specificity.
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CHAPTER 1: INTRODUCTION
My research is focused on statistical methods for discovery mass spectrometry proteomics
(often referred to as shotgun proteomics). The purpose of these experiments is to study the
abundance of proteins across of a large portion of the proteome. When scientists know what pro-
teins they want to examine, many different approaches can be used to estimate protein abundance.
But when the target is unknown or consists of a large class of proteins, then mass spectrometry
proteomics is usually the best technology available. A quintessential example of how and why this
technology is used can be found in the paper by Duncan et al. (2012). Their team was interested
in discovering why a class of cancer drugs called MEK inhibitors were not particularly effective
in fighting tumor growth. In theory, MEK inhibitors would block the activation of certain kinase
proteins which were known to play an important role in out of control cell signaling processes
found in cancer cells. Through first reducing their samples to activated kinase proteins they
hoped to gain insight into the cell signaling process. By comparing mass spectrometry data on
the untreated sample and the MEK inhibitor treated sample they discovered that the drug was
achieving the desired effect. ERK and c-MYK proteins which were targeted by the MEK inhibitor
were in fact inhibited in the treated sample. They were also able to observe that other kinases
were stimulated. This suggested that the drug was not effective because the cancer cells were
rerouting the cell signaling process. Had they simply looked for the proteins which they knew
were involved in the cell signaling process they likely would not have discovered this behavior.
This is precisely the advantage of a discovery proteomics experiment. Unfortunately the statisti-
cal modeling of this data is complicated. The technology presents two key features of paramount
importance from a statistical perspective; matched pairs data and non-ignorable missingness.
These two factors complicate everything from simple point estimation to downstream analyses
such hypothesis testing, correlation analysis and clustering. I will begin by exploring the current
1
literature and explaining the stages of the experimental process pertinent to statistical analysis.
2
CHAPTER 2: LITERATURE REVIEW
2.1 Experimental Basics
It is useful to begin a literature review by researching the methods frequently used in the field.
To this end I will start by examining the popular software packages MaxQuant and Inferno made
by the Max Planck Institute of Biochemistry and the Pacific Northwestern National Laboratory
respectively. Papers by Cox and Mann (2008) and Cox et al. (2014) along with a book on mass
spectrometry by Eidhammer et al. (2008) describe the basic details of analyzing data from MS/MS
experiments. MS/MS stand for Tandem Mass Spectrometry which implies that there are two
implementations the mass spectrometer. First the machine is used to separate peptides according
to their masses and count them. We will refer to this phase as ms1 and to the approximate counts
as intensities. Then after an initial counting the particles are smashed into smaller pieces which
are again measured by the mass spectrometer (the tandem step, ms2). This secondary reading is
essential for the identification of peptides and the proteins to which they belong. Unfortunately,
current technology does not allow us to select every particle which was measured during ms1 to be
selected for ms2. To resolve this issue one may pre-specify masses to select (targeted MS), select as
many as possible giving preference to the largest intensities from ms1 (data dependent acquisition,
DDA) or something in between these extremes can be done (data independent acquisition, DIA).
In this paper we will focus primarily on DDA. Within MS/MS with DDA, there are a number
of technologies that present their own strengths and weaknesses. We will examine three of them;
Stable isotope labeling by amino acids in cell culture (SILAC), Isobaric Tag for relative and
absolute quantitation (iTRAQ) and Label Free Quantification (LFQ).
3
2.1.1 SILAC
As explained in Cox and Mann (2008), a SILAC experiment distinguishes two samples, for
simplicity suppose we are comparing healthy lung tissue to cancerous lung tissue, by processing
the samples so that certain atoms in each sample contain only one version of an specific atomic
isotope. This isotopic labeling enables the tissues to be processed at the same time without losing
our ability to identify our samples at the end of the experiment. The processing of multiple
samples simultaneously is refereed to as multiplexing and it can provide a substantial reduction
in experimental variation, when modeled correctly. After labeling and measuring out two samples
the samples are processed into a solution of only proteins. The proteins are then digested with
Trypsin into protein fragments called peptides. Once a solution of peptides has been obtained
Liquid Chromatography (LC) will be used to begin separating peptides. This is essentially a way
of slowly removing peptides from the solution according to their hydrophobicity. This separation
of molecules through a tube is called elution. Similar particles, in terms of hydrophobicity, come
through the column in the same time frame. At the end of the column there will be a mechanism
to convert the peptide molecules into ions. With the technology used by the Chen Lab at
UNC this is achieved via Electrospray Ionization (ESI). Essentially as peptides flow towards the
end of the elution column they are charged with electricity until the solution obtains enough
energy to evaporate. What is left is a mist of charged peptide ions. These ions are then drawn
into a vacuum chamber leading into the mass spectrometer. From a statistical perspective it is
essential to point out that not all of the peptides become ionized. In fact the probability that
a peptide molecule becomes ionized will depend on the amino acid sequence of the peptide as
well as the other peptides that happened to be nearby during ionization. The importance of
this ionization will be discussed in depth at a later point but for now we will simply state that
this necessitates the estimation of relative protein ratios instead of absolute abundances. The
reason for all this ionization is that scientists have become exceptionally good at manipulating
ions. Once inside the mass spectrometer ions can be contained and forced into deterministic
patterns of movement. Then by forcing the ions to be ejected from a containment chamber at
known levels of energy the mass spectrometer can count all the ions that were ejected at a known
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mass to charge ratio. These counts are called intensities and the largest intensities are selected
in real time for the tandem step. Once selected, the molecules are broken apart further and
the component pieces are all measured to aid in identification of the peptide group. These mass
to charge counts are processed for each peptide through time as the molecules continue to be
processed through the elution tube. Eventually an entire peptide isotope group will be processed
by the mass spectrometer and software such as MaxQuant will be used to add up the results for
each grouping and identify, based on the mass to charge ratio, the peptide that the count applied
to. A good deal of effort goes into processing and identifying peptide groups but we will not focus
on that aspect.
2.1.2 LFQ
An LFQ experiment differs from SILAC in that no labeling of different samples ever occurs.
In the absence of multiplexing all experimental variation that effects peptides differently in each
run will be forced into the error term of a linear model. However, since LFQ methods do not
account for this variability experimentally, some efforts have been made to correct for the variation
mathematically. The MaxLFQ solution is a mathematical one as described by Cox et al. (2014).
Essentially they utilize the assumption that most protein fold changes will not change from one
condition to the next. Explicitly they state that the average protein fold change, on the log scale,
should be zero. They then fit multiplicative parameters to every observation from each sample
and fit those parameters in order to minimize the average squared protein level fold change. This
raises a number of important statistical questions. First we might wonder if the assumption of
no differential expression is at all reasonable. Similar assumptions were frequently used in the
world of microarray analysis but it is not clear that the situation should be analogous. Even in
the world of microarray studies the effects of normalization were hotly debated. For example the
standard technique called quantile normalization was challenged by Qiu et al. (2013). Even if the
assumption is valid it is not clear how well the technique of minimizing multiplicative parameters
will work. The justifications for this technique by Cox et al. (2014) are typically based around
high correlation levels between LFQ estimates and estimates from other techniques. This is not
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very convincing, since it says nothing about sensitivity or specificity but the focus of our research
will not be on the validity of LFQ techniques so this concern will not be elaborated upon. As
it stands, the scientific community appreciates the flexibility and ease of use provided by LFQ
methods and they seem to be growing in popularity despite the loss of precision relative to label
based methods.
2.1.3 iTRAQ
iTRAQ experiments, as explained by Karp et al. (2010) and Breitwieser et al. (2011), are
similar to SILAC in that different samples are processed together but varies considerably in
that the quantification step now occurs during the tandem MS stage (recall that in the SILAC
experiment the tandem stage was used purely for identification). Frequently iTRAQ experiments
will also implement Matrix Assisted Laser Desorption/Ionization (MALDI) to convert peptides
into ions. Basically the peptides are separated into chambers which will be blasted with lasers.
Once again, this ionization process occurs in probability and the number of molecules that end up
inside the mass spectrometer should not be assumed constant across techniques. Once in the mass
spectrometer the iTRAQ theory utilizes the vastly different masses of isobaric tags relative to
component peptides. Thus when a specific mass group is selected for tandem MS and broken apart
into secondary fragments measurements will be made on masses far away from the other amino
acid ions which represent the relative proportions of each tag. Frequently iTRAQ experiments
will simultaneously tag and process 4 or 8 different samples. Modern SILAC experiments are also
capable of processing multiple samples but the ability to handle multiple samples at once seems
to have been a major contributor to the popularity of iTRAQ technologies.
2.2 Modeling Efforts
Statisticians have made many models to analyze proteomics data. However there seems to
be a fairly large disconnect between the methods being made by statisticians and the methods
being implemented the most popular software packages. MaxQuant described by Cox and Mann
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(2008), Inferno by Polpitiya et al. (2008), ASAPRatio by Li et al. (2003) and ProteinPilot by
Shilov et al. (2007) all estimate proteins with either the mean or median peptide ratio. Inferno
is the only of those options that offers any alternatives based on average intensity. They have
three estimation procedures that they refer to as Rollups. ZRollup converts intensities to Z scores
and then takes the average Z score within a protein as the protein value. RRollup is essentially
the method of median ratios generalized for many samples and QRollup takes the average of the
upper 66% of peptide intensities as the average protein intensity. This last method aims to avoid
the trouble caused by missing data by staying away from peptides that are likely to be missing.
Somehow despite the overwhelming use of ratios in the scientific community statisticians seem to
have exclusively decided to model proteins as the average of their intensities. Basic linear models
were implemented by Oberg and Mahoney (2012) and Clough et al. (2012) which account for
ratios by including a factor for peptides. In the absence of missing data, taking contrasts on the
log scale, within statistical blocks based on peptides, will yield results very similar to an average
ratio based method. Thus, including peptide as a factor in a linear model is very similar to a mean
ratio method. However, this relationship breaks apart in the presence of non-ignorable missing
data. The papers describing the use of linear models in proteomics have focused on bringing the
advantages of traditional experimental design and statistical modeling to the field. This work has
been done admirably however many complexities of the data have been ignored in these papers.
One such complexity is the combination of both matched pairs and non-ignorable missingness
that makes protein contrasts deviate from median ratio estimates. Many other statisticians have
attempted to account for missing data bias. A review of missing data techniques in proteomics
by Taylor et al. (2013) compared three methods for removing missing data bias; an accelerated
failure time (AFT) model by Tekwe et al. (2012), a mixture model proposed by Karpievitch et al.
(2009) and K-Nearest Neighbors (KNN) imputation as described by Troyanskaya et al. (2001).
Notable additions to this group include three Bayesian methods. One method proposed by Luo
et al. (2009) models missing values with a logit function. The Bayesian model of Lucas et al.
(2012) attempts to account for missingness caused by misidentification and Koopmans et al.
(2014) proposes a model which allows for a random detection limit. Each of these methods leaves
something to be desired. Only the model by Luo et al. (2009) theoretically accounts for all the
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sources of missingness described above. The AFT model and the mixture model both assume
the existence of a fixed detection limit. But we should expect this detection limit to change
throughout time depending on what other compounds are being processed in the background.
Furthermore both of them assume that any missingness above this theoretical detection limit
should be missing at random with the mixture model explicitly categorizing all missingness as
either at random or due to a detection limit. Any technology using intensity dependent analysis,
will falsify this assumption. The interesting effort by Koopmans et al. (2014) which attempts to
model a random detection limit analyzes data at the protein level. In other words the estimation
within an experiment has already occurred and the only bias left to correct is at the population
level. Any missing data bias from the peptide level would inevitably be carried through to
the population level even with proteins that are never missing. As for the KNN solution, it is
difficult to imagine that there even could be a theoretical justification for imputing over 40% of a
dataset and then proceeding with an analysis as though the observations were real. Nonetheless,
this option has made its way into software packages such as Inferno (Formerly called Dante)
described by Polpitiya et al. (2008), so we will examine its efficacy later. In summary, there
are perfectly good methods for protein estimation that utilize the matched pairs nature of a
proteomics experiment. There are also perfectly good efforts to account for the missing data
bias intrinsic to all proteomics experiments. However, none of the models we found correctly
model both the mean structure, the missing data mechanism and provide solutions that properly
account for the variability caused by non-ignorable missingness. For this reason we will endeavor
to improve on the current methodology.
2.3 Modeling more complex experiments
In the last section we described some of the fundamental difficulties that arise when modeling
mass spectrometry discovery proteomics experiments. Unfortunately, many more complexities are
found when considering more experiments that involve replicates and multiple samples. When
dealing with the extended model, questions arise regarding which factors should be expected to
interact with one another. Theoretically, there is a concern that variations in ionization efficiency
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could result in very different intensities for a given peptide from run to run. In both SILAC and
iTRAQ experiments we have good reason to believe that the ionization efficiency for a peptide
will be the same across samples, since they are all ionized under the same conditions. However,
the efficiency can vary dramatically from run to run. Richard Knochenmuss convincingly demon-
strates that when using Matrix Assisted Laser Desorption/Ionization (MALDI), the most common
ionization technology used in iTRAQ experiments, by simply altering the amount of sample pro-
cessed, the rank order of the intensities measured can be completely reversed (Knochenmuss,
2012). He ascribes this behavior to the complicated nature of electrons transfers that occur in
the ion plume. Essentially, the factors that determine ionization efficiency are highly multivariate
and for the most part unobserved. Furthermore, these unobserved factors are bound to change
when experiments are replicated because the background analytes (other chemical structures that
are ionized at the same time as a target peptide) will always change due to variations in the elu-
tion process. The result is a large amount of variation in peptide level intensities that we would
greatly like to remove from our estimation procedure. Schliekelman and Liu (2014) estimated
that the effect of background peptides on the probability that a peptide would be observed in a
sample exceeded the effect of the abundance of a peptide molecule. For these reasons we believe
it is essential to model ionization efficiency as an outcome dependent on a peptide by run inter-
action. However this is only possible in multiplexed experiments, and even when possible it is
not clear that statisticians agree on the importance of this term. The model by Oberg and Vitek
(2009) uses many interactions but a peptide by run interaction is not even discussed. In addi-
tion to complications with the mean structure of a proteomics model, the extended experiment
poses complicated questions about the very nature of a missing value in a mass spectrometry
experiment. In a basic ANOVA model framework, as described by Scheffe´ (1999), the indices of
each data point and factor are given a priori. So a missing data point is any value defined in
the indices that does not have an observed value. In a discovery mass spectrometry experiment
this is not the case. We do not know in advance what peptides will be observed, thus we do
not know the range of our indices. In the simple case, comparing only two samples, it is natural
to consider missing values to be peptides that were observed in one sample but not the other.
With replicates and multiple samples it is no longer clear what we want to include in the set of
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missing values. One might claim that since we know the complete amino acid sequence of each
protein, that any part of the sequence for which we do not have a value is a missing data point.
This sounds sensible, however nobody does this because many of those peptides might have had
zero probability of being observed due to low ionization efficiency. If a potential outcome has
probability zero of being observed does it make sense to call it missing? More pragmatically, can
information on such missing data patterns be at all useful? These are the questions that need to
be addressed before efforts can be made to model more complicated proteomics experiments.
2.4 Clustering
The statistical techniques commonly used in proteomics studies go beyond experimental mod-
eling and point estimation. One technique common to proteomics studies is data clustering. The
assignment of data into various clusters has been a multidisciplinary objective since at least
1956 when Steinhaus (1956) proposed the method of k-means clustering. Essentially this method
groups samples into k somewhat evenly sized groups with members of each group having small
Euclidean distance. In the world of cancer biology clustering became a very popular topic af-
ter a method called hierarchical clustering, described in detail by Hastie et al. (2009), was used
to discover new subtypes of breast cancer by Sø rlie et al. (2001). Now clustering has become
a commonly used tool throughout the omics fields and proteomics is no exception. A natural
research topic would be to explore how intensity dependent missingness effects clustering algo-
rithms. There does not appear to be a lot of work on this topic but a paper by de Brevern
et al. (2004) demonstrated with microarray data that if as little as one percent of the data were
missing at random it could greatly destabilize clustering results. Considering that mass spec-
trometry data could have upwards of 40% missing data this demonstrated a strong need for
further research. However it also raised the much more fundamental question of how two sets of
clustering assignments should be compared. de Brevern et al. (2004) used what they called the
conserved pairs proportion (CPP). This is just the number of pairs that were linked together in
both methods divided by the total number of possible pairs. It turns out the CPP is far from
the only way to compare two clusters. The most common tool is called the Rand Index proposed
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by Rand (1971). This index counts the number of elements which were grouped together in both
plus the number of pairs that were not linked together in both methods all divided by the total
number of possible pairs. The Rand index may be the most common index used for comparing
two clustering assignments but the story does not end here. In a paper by Albatineh et al. (2006)
28 different indices for comparing cluster assignments were identified. Although researchers have
been using such indices since at least 1971 very few arguments exist to convincingly demonstrate
why any of these indices should be preferable to another. Furthermore it turns out that there
are rarely any good reasons to prefer one clustering method over another, and there are many,
many clustering algorithms. Aside from K-Means and Hierarchical Clustering, Mixture Models
(McLachlan and Basford (1987)), Self Organizing Maps (Kohonen (1982)), Spectral Clustering
(Hagen and Kahng (1992)), Fuzzy Clustering (Dunn (1973)) and Consensus Clustering (Monti
et al. (2003)) are just a small subset of the clustering algorithms available. Jain (2010) report
that there are actually thousands of clustering algorithms to choose from. They argue that the
reason for this multitude of methodologies is that clustering is not a well defined problem. Any
set of data can be split up length wise, width wise, in circles or any other creative way that a
researcher might be inclined to try, and each one of those splits might be perfectly interesting
for different reasons. Without the type of mathematical population model we routinely see in
inference problems it becomes very difficult to argue which way someone should split up a set of
data. Although different algorithms are likely to outperform each other depending on the specific
setting, the indices appear to have a more well defined purpose. Albatineh (2010) show that
almost all of the clustering indices belong to a family based on an underlying 2x2 table counting
the number of pairs that were matched together in each combination of clusters. They also sim-
plify the process of comparing these indices by deriving mathematical properties of this family
that allow for easy computation of expectations and variances. We found their exploration to
be highly useful but believe it did not go far enough into investigating the nature of this family.
In Chapter 4 we argue that a subset of this family allows us to put cluster evaluation into a
commonly accepted statistical framework. This framework is necessary to begin an exploration
of the effects of proteomic missingness on clustering methods however that exploration will have
to remain a topic for future research.
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CHAPTER 3: PROTEOMIC MODELING
3.1 Introduction
At the highest level, proteomics is the large scale study of the structure and functions of pro-
teins. An important class of studies within this field is shotgun, or discovery, proteomics. These
experiments are designed to provide information on a large set of proteins that are not specified
before conducting the experiment. Discovery proteomics experiments typically necessitate the
use of a mass spectrometer which entails an inferential step between the readings of the mass
spectrometer and the protein level outcomes of interest. Understanding the details of these exper-
iments becomes essential in order to conduct a sensible analysis of proteomics data. A statistician
might be fooled by the superficial similarities between microarray and proteomics data into sim-
ply adopting microarray methods to be used on protein data. Although the outcomes in the
experiments share the same “intensity” designation, in reality the similarities end with the name.
In a microarray experiment, an intensity refers to the observed brightness of a dye that will be
present when a reaction occurs with some target molecule. The exact relationship between this
intensity and the underlying molecular abundance is unclear but, as explained by Dabney and
Storey (2007), a researcher at least believes the intensity to be a monotone increasing function
of the analyte concentration. Nothing of the sort can be claimed for intensities from shotgun
proteomics experiments. To justify this statement it will be necessary to provide a basic overview
of the shotgun proteomics experiment, including a detailed explanation of the ionization process
and the different sources of missing data. We will show how the experimental details create two
statistical features characteristic of all shotgun proteomics experiments; matched pairs data and
non ignorable missingness. After justifying these features we propose a model that accounts for
them and test the performance of this model on both simulated and real data.
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3.1.1 Bottom Up Relative Quantification Experiments
Discovery proteomics experiments are usually a type of relative quantification experiment (Ei-
dhammer et al., 2008). The implication here is that the experiment can only be used to provide
measures of protein abundance in one sample relative to another, without ever obtaining mea-
sures of the absolute abundance in either sample. Many experiments will compare samples from
numerous conditions but the simplest scenario is a comparison of protein abundances between
two samples: Sample A and Sample B. A number of relative quantification workflows are available
for proteomics to achieve this goal. These include Label-Free Quantification (LFQ) (Cox et al.,
2014), Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) (Cox and Mann, 2008)
and Isobaric Tags for Relative and Absolute Quantification (iTRAQ) (Ross et al., 2004). The
detailed workflows involved in these experiments are important and should determine the types
of model that a statistician would consider. For instance the model proposed in this paper works
for SILAC and LFQ data, but the missing data mechanism we employ is inappropriate for an
iTRAQ experiment. Nonetheless a full explanation of each experimental workflow is not neces-
sary for our purposes. The experiments described here are referred to as bottom-up proteomic
methods, because proteins are too large to be identified by mass which forces us to make inference
about relative protein abundance from measurements obtained on amino acid fragments called
peptides. A typical bottom-up proteomic workflow involves the extraction of proteins from cells,
tissues or biological secretions/fluids, followed by proteolysis which breaks proteins into peptides.
Typically this is done by adding an enzyme called trypsin that specifically cleaves proteins at
lysine and arginine amino acid residues. After this digestion occurs peptides from the sample
are separated according to each peptides hydrophobicity in a process called elution, where the
more hydrophobic peptides will be the last to separate. After elution, peptides will travel to-
wards an ionization device which converts the peptides into ions so that they may enter and
be manipulated by a mass spectrometer. The ionization is usually done with electricity in the
form of electrospray ionization (ESI) or with lasers by matrix-assisted laser desorption/ionization
(MALDI). It is important to emphasize that both of these ionization technologies affect large
numbers of peptides all at the same time and not all of them will successfully ionize. The elution
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process aims to completely separate each group of peptides but it does not work perfectly. When
referring to the measurement made on a specific peptide we may refer to all of the other peptides
that were ionized at the same time as co-eluting peptides. Co-eluting peptides play an important
role in determining the probability of ionization. After ionization the newly formed peptide ions
are manipulated by a mass spectrometer which is capable of separating the ions according to their
mass and counting the number of ions corresponding to each mass. Peptides with a large counts
will be selected for fragmentation and a second mass spectrometry reading of the fragments. The
process of selecting peptides for a second mass spectrometry step based on the relative magnitude
of the counts is called data-dependent analysis. The second mass spectrometry step is mostly
used to identify the peptides that were just counted (quantification also happens during this step
in an iTRAQ experiment). A summary of the ion counts for each now identified peptide, usually
computed as the area under a curve from a plot of counts through time (Cox and Mann, 2008),
is referred to as a peptide intensity. A more comprehensive description of the LFQ workflow can
be found in a paper by Sandin et al. (2011). For the purposes of this paper we will focus on only
the experimental details which motivated our statistical model.
3.1.2 Matched Pairs Data
Mass spectrometers work with ions because advances in technology have given us a tremendous
ability to manipulate ions. For this reason ionization of peptide molecules is an indispensable
aspect of a mass spectrometry proteomics experiment. Unfortunately, and this is a critical point,
not all of the peptides from the sample will be ionized. Certain peptides tend to ionize more
efficiently, while others will not ionize at all. The probability that a given peptide molecule
will be ionized can be referred to as ionization efficiency. Ionization efficiency is believed to be
a property of both the chemical structure of each peptide and the presence of other co-eluting
peptides, sometimes referred to as matrix interferences. Schliekelman and Liu (2014) found that
competition for charge between background peptides may actually be a more important factor
than abundance in determining if a peptide will be detected. Regardless of what factors are
most important, ionization efficiency can cause the proportion of peptides that enter into the
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Table 3.1: This table shows the relationship between relative protein abundance and the inten-
sities of a peptide belonging to that protein. p is the probability that the peptide ionizes and
makes its way into the mass spectrometer. pW and pZ represent the expected intensities from
samples A and B respectively.
Protein Abundance Peptide Abundance Ion Abundance
Sample A X W pW
Sample B Y Z pZ
Ratio XY = µ
W
Z =
X
Y = µ
pW
pZ = µ
mass spectrometer to be drastically altered. This is why we previously claimed that peptide
intensities are not a monotone increasing function of peptide concentrations. One peptide might
be far more abundant than another in the original sample but a lower ionization efficiency could
reverse the relationship for peptide intensities. What we observe is the number of peptides in
solution multiplied by that peptide’s ionization efficiency. Fortunately, if the efficiency parameter
is a property of the individual peptide, it will cancel out when put into a ratio with the same
peptide from the other sample. This relationship is outlined in Table 3.1. In a SILAC experiment
every peptide in both samples will be processed at the same time and thus will be exposed to
the same conditions yielding identical ionization efficiencies. However, even in a SILAC replicate
the efficiency may be altered due to variations in sample preparation and elution time resulting
in a different profile for the background peptides. For a Label-Free experiment, run to run
variation should always be expected. So unless the researchers have good reason to assume the
ionization efficiencies will be equivalent, the outcomes may be confounded by run to run variation
affecting each peptide differently. The incomplete and inconsistent ionization of analytes makes
it impossible to accurately measure the abundance of proteins from the original sample. However
in ratio form we can still make inference about the relative abundance of proteins in two samples.
This is why proteomics experiments are often referred to as relative quantification experiments
and it is why popular proteomics software packages, such as MaxQuant (Cox and Mann, 2008)
estimate log protein ratios as the median of log peptide ratios. Similar methods dominate the
techniques discussed by Eidhammer et al. (2008). Despite the ubiquity of median ratio estimates
in proteomics software packages, none of the models we found in the literature make use of peptide
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level ratios beyond including peptide as a covariate in a linear model. Instead, most statistical
methods estimate the log protein ratio from Sample A to B by taking the average log intensity
across all peptides within the protein from Sample A and then subtracting the average log intensity
from all peptides within the protein from sample B. In the absence of missing data these methods
are almost identical since E(X − Y ) = E(X) − E(Y ). However, in the presence of wide-spread
missing data many peptides are detected in only one of the two samples. This makes it difficult
to interpret the results from a method based on average intensities. Unfortunately wide-spread
missingness is unavoidable in a discovery mass spectrometry experiment as explained below.
3.1.3 Intensity-Dependent Missingness
Unlike microarray experiments in which missing values often comprise about 1-11% of the
data (de Brevern et al., 2004), proteomics data sets almost always have a much higher percentage
of missing data. In the dataset analyzed in this paper 25% of the peptides were missing and
according to Karpievitch et al. (2009), 50% missing values are not uncommon. For this reason,
the way we conceptualize and treat the missing data will take on huge importance. Here we will
briefly discuss some of the largest causes of missing data.
Detection Limit
Mass spectrometers have both theoretical and a practical limits of detection (LOD). The
theoretical LOD is the minimum number of ions a given instrument can capture and produce an
ion current with adequate signal enhancement. Although any peptide exceeding this number of
ions can theoretically be detected by the mass spectrometer every sample contains far more than
one peptide which results in a considerable amount of noise. This noise results in a practical
detection limit, which is dependent on the sample itself, whereby the software fails to distinguish
peptide peaks from background noise. For this reason, sample-related factors that either result
in a higher practical detection limit or a decreased intensity due to the nature of the sample can
result in missing values. As previously discussed, a major driver in this setting is the peptide
16
ionization efficiency. If the ionization efficiency is low then the intensity will be low and may
fall below the detection limit. This is clearly a form of non-ignorable missingness where the
probability of being missing is directly related to the magnitude of the intensity.
Data-Dependent Tandem Mass Spectrometry
Most mass spectrometers performing data-dependent analysis (DDA) do not succeed in frag-
menting every ionized peptide. Peptides are mass selected (isolated) for a tandem MS (MS/MS)
step according to their intensity rank order. This tandem mass spectrometry step is where peptide
identification occurs, so any peptide signal that is not selected for tandem mass spectrometry will
not yield useful data. On a side note, in an iTRAQ experiment quantification also occurs in the
tandem step whereas in LFQ and SILAC experiments quantification occurs during the first MS
step. This is why our proposed missing data mechanism does not apply to iTRAQ experiments.
The data that we analyze in this paper was generated from a Q Exactive mass spectrometer
made by Thermo Scientific, which was only capable of capturing approximately 80% of the peak
intensities above the LOD. Thus even above the practical LOD an intensity dependent process
can result in missing values. The number of detectable (identifiable) features can be increased
with advances in the operating speed of the device, and complete parallelization can be achieved
in newer Orbitrap instruments (Lesur and Domon, 2015). However, this results in a trade off
where the identification process becomes less certain. In most settings we will have to consider
two sources of non ignorable missingness, one which occurs below a frequently changing detection
limit and another above.
Misidentified/Unmatchable/Razor Peptides
A peptide might appear in one sample and not in another simply because it was misidentified.
Matching algorithms are designed to minimize this problem but it undoubtedly still exists. A
similar problem comes from razor peptides. These are peptides that are properly identified but
that could belong to more than one protein. Many software programs assign razor peptides to
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the protein that has the most peptide level evidence based on the Occam’s Razor concept of
protein parsimony (Cox and Mann, 2008). Yet this process could result in misidentification and
consequently, missing values. It is also possible that a particular peptide will simply fail to be
identified with any certainty which will also result in missing values. It is probably safe to classify
missingness caused by classification errors as missing at random.
Modeling Missingness
Many efforts have been made to correct for missing data biases in mass spectrometry experi-
ments. A review of missing data techniques in proteomics by Taylor et al. (2013) compared three
methods for removing missing data bias: an accelerated failure time (AFT) model by Tekwe
et al. (2012), a mixture model proposed by Karpievitch et al. (2009) and K-Nearest Neighbors
(KNN) imputation as described by Troyanskaya et al. (2001). Notable additions to this group
include three Bayesian methods. One method proposed by Luo et al. (2009) models missing
probabilities with a logit function. The Bayesian model of Lucas et al. (2012) attempts to ac-
count for missingness caused by misidentification and Koopmans et al. (2014) proposes a model
which allows for a random detection limit. However, none of these methods utilize peptide level
ratios in their solutions which leaves room for improvement. On their merits as purely missing
data techniques, only the model by Luo et al. (2009) theoretically accounts for all the sources
of missingness described above. The AFT model and the mixture model both assume a fixed
detection limit. But we should expect this detection limit to vary from peptide to peptide de-
pending on what other compounds are being processed in the background. Furthermore, both
of them assume that any missingness above this theoretical detection limit should be missing at
random with the mixture model explicitly categorizing all missingness as either at random or due
to a detection limit. The use of any technology which uses Data Dependent Analysis will make
this assumption false since data dependent analysis is a form of intensity dependent missingness
that occurs above the detection limit. The interesting effort by Koopmans et al. (2014) which
attempts to model a random detection limit analyzes data at the protein level. In other words,
the estimation within an experiment has already occurred and it is unclear what missing data
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bias can be corrected. As for the KNN approach, it is difficult to imagine that there even could
be a theoretical justification for imputing 40% of a dataset and then proceeding with an analysis
as though the observations were real. Nonetheless, this option has made its way into software
packages such as Inferno (Formerly called Dante) described by Polpitiya et al. (2008), so we will
examine its efficacy later. The problem of ascertaining the cause of a missing value is probably
intractable. However, we can say with some confidence that the probability of an intensity being
missing should be a monotone increasing function of the intensity. Although the exact conditions
and sources of missingness will vary from peptide to peptide and experiment to experiment a
single monotone parametrized function of the probability of missingness could serve as a useful
approximation for the conglomeration of missing data sources. For this reason, along with some
mathematical niceties, we model a probit missing data mechanism such that for each peptide the
probability of being observed is given by Φ(a + by) where Φ is the standard normal CDF, y is
the peptide intensity, and a and b are missingness parameters to be estimated in our analysis.
3.2 Methods
In order to symmetrically model log peptide intensities, for the rest of the paper we will refer
to intensities only on the log scale, for each peptide we frame the problem in terms of the protein
fold change (the difference between the intensities) and the midpoint of the two peptides,
Yijk ∼ N(αj(i) + (−1)k+1
µi
2
, σ)
where Yi,j,k is the intensity of the jth peptide within the ith protein from the kth sample,
k = 1, 2, i = 1, . . . , n indexes the unique proteins in the samples and j = 1, . . . ,mi indexes the
peptides within the ith protein, αj(i) represents the midpoint of the two intensities of peptide
j within protein i and µi represents the protein fold change. The notation N(β, σ) denotes a
normal random variable with mean β and variance σ. The mixed model definition is completed
with αj(i) ∼ N(βα, ξ) independent from µi ∼ N(βµ, τ).
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This midpoint mixed model (M3) provides a symmetric framework for analyzing a proteomics
experiment in one statistical model while accounting for the matched pairs nature of the data.
The model can easily be fit using standard software such as PROC MIXED in SAS or lme from
the NLME package in R. We expect this model to provide similar results to standard ratio-
based methods and improved downstream analysis by creating a single estimate of experimental
variance. In fact, if we used fixed effects in place of random effects M3 is a reparameterization of a
linear model with covariates for peptide within protein, sample, and a sample*protein interaction.
Of course this model completely fails to account for missing data bias. We expand the M3 model
into a selection model with a probit missingness mechanism. We refer to this new model as the
midpoint mixed model with a missingness mechanism (M5). Let I() be an indicator function so
that Rijk = I(Yijk is observed). We assume (Rijk|Yijk) ∼ Bernoulli(Φ(a+ bYijk)).
Fitting this model is greatly complicated by the number of missing values in a proteomics
experiment. In our dataset, there were certain proteins with over 200 missing values, and in-
tegrating the likelihood 200 times created computational difficulties. We resolved this issue by
giving each parameter a non-informative prior and using a Gibbs Sampler. The Gibbs Sampler
required three sampling steps that were non-standard: the distribution of a missing value given
everything else f(Yijk|µi,αi,Yijk′ ,θ,R), where Yijk′ is the matched pair corresponding to the missing
value and θ is the vector of parameters (a, b, τ, ξ, σ, βα, βµ); the distribution of a protein fold
change given everything else f(µi|αi,Y,θ,R); and the distribution of a midpoint given everything
else f(αj(i)|µi,Y,θ,R). A bit of manipulation reveals that the distribution of a missing value follows
the Extended Skew Normal distribution as described by Azzalini and Capitanio (2014).
f(Yijk|µi,αi,j ,Yijk′ ,θ,R)(x) =
φ(x−µx√
σ
)Φ(−a− bx)
√
σΦ(ω)
where
µx = αj(i) + (−1)k+1
µi
2
, ω =
−a− bµx√
1 + σb2
.
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Table 3.2: The prior and posterior distributions used to complete the model. The parameters
with non standard prior and posterior distributions are described in the text.
Parameter Prior Posterior
τ IG(.001, .001) IG(.001 + n/2, .001 +
∑
µi−βµ
2 )
ξ IG(.001, .001) IG(.001 +
∑
mi/2, .001 +
∑
αi−βα
2 )
σ IG(.001, .001) IG(.001 +
∑
2 ∗mi/2, .001 +
∑
i
2 )
βα N(0, 10000) N(
∑
αi,j/ξ, (
1
10000 +
∑
mi
ξ ))
βµ N(0, 10000) N(
∑
µi/τ, (
1
10000 +
∑
n
τ ))
a N(0, 10000) Probit Regression Estimation
b N(0, 10000) Probit Regression Estimation
We also find that
(µi|αi,Y, θ,R) ∼ N
(
βµσ +
τ
2
∑
j (yij1 − yij2)
σ + miτ2
,
στ
σ + miτ2
)
,
and
(αij |µi,Y, θ,R) ∼ N
(
βασ + ξ(yij1 + yij2)
σ + 2ξ
,
ξσ
σ + 2ξ
)
.
Proofs of these results can be found in Appendix 6. Although these formulas are complex the
results are somewhat intuitive. Each missing value from a pair of points comes from a skew
normal distribution where the skew is determined by the missing data mechanism. The fold
change comes from a distribution centered around a weighted average of the mean protein fold
change and the average of the observed differences in peptide intensities. The peptide midpoint
is drawn from a distribution centered around a weighted average of the mean peptide midpoint
and the observed midpoint of the pair of intensities.
The Bayesian model formulation is completed with the priors in Table 3.2. The posterior
distribution of (a, b) is estimated by fitting the probit regression model
Φ−1(E[Rijk|yijk]) = a+ byijk
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The posterior distribution is then approximated as
a
b
 ∼ N(
aˆ
bˆ
 , Σˆ)
Where aˆ, bˆ and Σˆ are the parameter estimates from the probit regression and their corresponding
covariance estimate, respectively. The bivariate normal distribution used here approximates the
posterior distribution as a consequence of Bayesian large sample theory (Gelman et al., 2004,
chap. 4).
3.2.1 Simulation Study
To explore the potential benefits of the M5 model, we conduct simulations to compare the ac-
curacy of our estimates to six other estimation procedures. In addition to the M3 and M5 models,
we analyze the commonly used method of median ratios, a one-way ANOVA for protein within
sample, QRollup and QRollup performed after implementing a weighted K-Nearest Neighbors
imputation (KNNQ). QRollup is a method of analyzing average intensities that seeks to avoid
missing data bias by analyzing only the largest 66% of the intensities within each protein/sample
combination. A software package called Inferno implements the QRollup method(Polpitiya et al.,
2008). Similar approaches are discussed by Eidhammer et al. (2008). The Inferno software also
offers an option to use Weighted K-Nearest Neighbors Imputation, which is why we coupled impu-
tation with the QRollup method. The ANOVA model is intentionally simpler than that described
by Oberg and Mahoney (2012), as we wanted to use an example of a model where proteins are
estimated as the average intensity within groups regardless of the presence of a matched pair.
Linear models that include peptide as a covariate should perform similarly to the M3 model.
This set of methods gives us a look at the performance of three methods based on ratios and
three methods based on average intensities. All methods, except for M3 and M5, are currently
supported by proteomic software packages.
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In our simulation the hyperparameter values were
τ = 9, ξ = 4, σ = .3, a = −9, b = .5, βα = 18.5, βµ = 0.
We generated 500 protein fold changes from a N(βµ, τ) distribution and generated the number of
constituent peptides within each protein by sampling with replacement from the set {1, ..., 12}.
For each peptide we generated independent random midpoints from a N(βα, ξ) distribution. We
generated independent residual errors, ijk as N(0, σ) random variables. Then we created inten-
sities yijk = αj(i) + (−1)k+1 µi2 + ijk. Next we simulated missingness by computing probabilities
of missingness for each intensity as pijk = Φ(a+ byijk), then we randomly drew Bernoulli random
variables, (Rijk), according to those probabilities, to identify which yijk are missing. We then fit
all six models including 1,000 draws from the M5 Gibbs Sampler to create M5 estimates. Results
were recorded and the whole process was repeated 100 times.
3.2.2 Protein Categories
Before comparing the six methods, some classification of observation patterns is needed since
not all methods are capable of estimating the same proteins. To this end we classify each protein
as “matched”, “unmatched”, “one-sided” or “missing”. Figure 3.1 presents a visual depiction.
Missing proteins are proteins for which peptides were identified but no peptide intensities
were observed. These are not interesting and even though they can be estimated with M3, M5 or
KNNQ we recommend just removing them from the study. Matched proteins are proteins that
have at least one matched peptide pair. With at least one shared peptide from each sample,
all of the methods can be used for estimation. An unmatched protein has observed intensities
from each sample but no peptides that are quantified in both samples. One-Sided proteins have
intensities from peptides in only one sample and are completely missing in the other. This can be
indicative of a large fold change difference. M5, M3 and KNNQ can be used to estimate all types
of proteins. The ANOVA model and QRollup can be used for both matched and unmatched
proteins while the method of median ratios can only be used on matched proteins.
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Figure 3.1: The three categories of proteins. Matched proteins contain at least one matched
peptide pair. Unmatched proteins contain data from both conditions but no matched pairs.
One-sided proteins contain peptide measurements from only one sample.
3.2.3 Simulation Results
The sampling chains all appeared to achieve stationary distributions after about 300 draws
(in the real data this was achieved within 50). For this reason, our estimates were based on the
posterior mean after a burn in length of 500 draws.
Figure 3.2 shows the distribution of mean squared errors across simulations. The most obvious
result here is that the methods based on ratios are far outperforming methods based on average
intensities. M5 demonstrates the best performance with an average MSE of 0.26. The method
of medians was the second most accurate with an MSE of 0.35, which represents an increase in
error of 35%. This is a fairly large increase but it is hardly noticeable relative to the error coming
from the average intensity methods. The best of these was QRollup with an average MSE of 1,
which represents an increase of 285%. It should be noted that the commonly used validation tool
of correlation does not do a very good job of assessing algorithmic weaknesses here. Figure 3.3
shows that even though some of these methods more than sextuple mean squared error, the
lowest correlation coefficient is still above 0.9. It should also be noted that the use of Weighted
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Figure 3.2: MSE for each method computed across matched Proteins and within each simulation.
K-Nearest Neighbors appears to be detrimental to the accuracy of QRollup estimates.
These relationships can be further explored by categorizing proteins according to the percent-
age of peptides which are missing as shown in Figure 3.4. This plot shows that the error for the
KNNQ method increases substantially once more than 50% of the data requires imputation. In
this chart we can see that, as missingness increases, the ANOVA estimation also loses accuracy
at a much faster rate than the other methods. This is likely because the ANOVA model simply
reports average intensities within each sample regardless of the amount of missing data.
In the case of one-sided and unmatched Proteins the method of medians is obviously not
applicable. Among the other methods the rank ordering based on average MSE remains the
same. (see Figure 3.5).
In this case the average MSE for M5 is 1.5 and the second best is the M3 model at 2.4. The
best average intensity method was the ANOVA model with an MSE of 3. Correlation coefficients
are much weaker in this category as pictured in Figure 3.6.
Arguably the greatest advantage to using the M5 model comes from the ability to estimate
one-sided proteins. These proteins are difficult to estimate since one of the samples provides no
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Figure 3.3: Scatterplot of true simulated fold changes for matched Proteins vs their estimates
across all simulations. Correlation coefficients are also computed across all simulations.
Figure 3.4: MSE for each method according to categories of the percentage of missing peptides.
The MSE for KNNQ at 75% missing data is 12.81 which was too extreme to be plotted along
with the other methods.
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Figure 3.5: MSE for each method computed across unmatched proteins and within each simula-
tion. The method of medians, MED, is not applicable to unmatched proteins.
Figure 3.6: Scatterplot of true simulated fold changes for unmatched proteins vs their estimates
across all simulations. Correlation coefficients are computed across all simulations.
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Figure 3.7: MSE for each method computed across One-Sided proteins and within each simulation.
The method of medians (MED), ANOVA, and QRollup (Q) are not applicable to One-Sided
proteins
observed values. Keep in mind for a One-Sided protein that we could assume that the abundance
of the missing value is between zero and the detection limit. However, the upper bound on an
abundance ratio is infinite. Nonetheless, M5 does provide decent estimates in this situation as
can be seen in Figure 3.7. Only three methods were capable of estimating one-sided proteins and
only one of them could be considered useful. The MSE’s for M5, M3 and KNNQ were respectively
2.7, 8.6 and 27. The range of the log-scale fold changes in this simulation were roughly -10 to
10. So an average MSE for M5 of 2.7 is certainly small enough for the estimates to be of interest.
The scatter plot in Figure 3.8 strongly highlights the advantages of the M5 model.
3.3 Breast Cancer Data
In order to make sure the results of our simulation study are not artifacts of the data generation
procedure, we also analyzed the effect of non-informative missingness on a real data set. The
data, generated by the Chen Biochemistry Lab, contains peptide level LFQ measurements from
two samples of breast cancer tissue (one Basal and one Luminal). This dataset can be found in
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Figure 3.8: Scatter plot of true simulated fold changes for one-sided proteins vs their estimates
across all simulations. Correlation coefficients are computed across all simulations.
the supplementary material. 11,866 unique proteins were identified in the data, of these 594 were
Missing, 9,265 had at least one peptide pair, 1,810 were one-sided and 197 had intensities in both
samples but no matched pairs. This breakdown is pictured in Figure 3.9.
Not considering missing proteins, we can see that before we even do an analysis the M5
model is capable of estimating an additional 2,007 (22%) proteins compared with the method of
medians. This would be a substantial gain if our method is capable of estimating those proteins
Figure 3.9: Distribution of proteins in the tumor data.
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Figure 3.10: M5 estimates of the log fold change between proteins found in Basal and Luminal
breast cancer tissues. Only proteins with 95% credible intervals that do not contain zero are
pictured.
with a decent level of accuracy as our simulations suggest. Furthermore, the entire data set
contains information on 248,342 peptides, 61,418 (about 25%) of which are missing. There is a
tremendous amount of information in the patterns of those 61,418 missing values, and in theory
the M5 model takes full advantage of them. M5 model estimates were computed on a random set
of 1,000 proteins and 95% credible regions were computed. 1,000 draws from the Gibbs sampler
were used with a burn in length of 500. We reduced the data size purely for computational
simplicity. From the 1,000 proteins, 252 matched Proteins and 4 one-sided Proteins did not
contain zero in their credible intervals (Figure 3.10). Among the 4 one-sided Proteins is protein
O75363 which is better known as the gene product for the Novel Amplified in Breast Cancer-1
gene (NABC1). This gene is known to be involved in cancer typically being up-regulated in
breast cancers and down-regulated in colon cancer (Beardsley et al., 2003). Since this protein
was one-sided in our dataset no useful information regarding NABC1 would have been found
without the M5 model. After estimation, we computed the square of the M5 estimates divided
by the posterior standard deviation. The proteins were then ranked in descending order and are
presented in Table 3.3. We also used the real data to study the effects of non-ignorable missingness
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Table 3.3: Twenty proteins ordered by the highest squared ratio of posterior mean to posterior
standard error. At the bottom of the table is the complete set of one-sided proteins for which
the credible region did not include zero.
Protein Estimate Posterior SD Category
P48681 -5.39 0.300 Matched
O95425 -3.72 0.230 Matched
O76070 5.31 0.420 Matched
Q13557 -2.64 0.231 Matched
F8VTL3 -1.89 0.169 Matched
Q07065 -2.33 0.211 Matched
Q13813 -0.97 0.096 Matched
P12270 -1.12 0.112 Matched
G3XAI2 -2.26 0.241 Matched
Q9Y4L1 -1.42 0.163 Matched
P97457 4.653 0.597 Matched
Q86SF2 3.39 0.436 Matched
O60231 -1.93 0.25 Matched
Q13363 3.58 0.501 Matched
Q9NX62 2.16 0.302 Matched
Q5T6V5 3.02 0.426 Matched
Q86WJ1 -2.70 0.386 Matched
P23786 1.77 0.261 Matched
Q6BCY4 -2.55 0.376 Matched
Q9NP74 -2.37 0.357 Matched
P12109 -3.59 0.813 One-sided
Q16666 1.76 0.823 One-sided
B4E1Z4 2.55 0.817 One-sided
O75363 2.90 0.944 One-sided
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on each of the six estimation methods. To accomplish this goal we first reduce the data to allow
a complete case analysis, so that only peptides with observed intensities from both samples are
included in the reduced dataset. From this complete-case data, 500 proteins were randomly
selected for a sensitivity analysis. The mean peptide ratio within each protein was calculated
and considered to be the reference value. We explored what happens to the estimates from each
model as higher levels of intensity-dependent missingness are introduced. Appropriate values of
the missingness parameter b were discovered by trial and error to provide overall missingness
levels of 1, 5, 10, 20, 30, 40 and 50 percent. Mean squared error was then calculated for each of
the six methods on all 7 datasets.
3.3.1 Results of the Sensitivity Analysis
We explored the effect of intensity dependent missingness on complete case estimates. The
performance demonstrated similar patterns to what we found in the simulation analysis with
ratio based methods having far more stable estimates than the average intensity based methods,
shown in Figure 3.11.
These plots paint a picture consistent with the results from the simulation study. The M5
model outperforms all other methods. The method of median ratios and the M3 model have
very similar performance. The ANOVA model and QRollup methods perform comparably to
the ratio-based methods until the missingness is increased to around 10%. Once missingness hits
40%, the difference in frameworks becomes substantial, and at 50% the average MSE from KNNQ
is about eleven times higher than that from the M5 model.
3.4 Misspecification of the Missing Data Mechanism
An obvious artificial strength of the simulation study is the use of the same missing data
mechanism in both the simulation and the analysis. The scientific process supports the use of
a missing data mechanism in which the probability of a peptide being observed is a monotone
increasing function of the intensity. Beyond this basic structure very little evidence exists to
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Figure 3.11: MSE computed as the average squared difference between the estimate from a
complete case analysis and the estimate from a dataset with simulated intensity dependent miss-
ingness. MSE for QRollup with weighted KNN imputation takes the values 2.34 and 3.31 at 40
and 50 percent missingness respectively. These values were too extreme to be plotted with the
other methods.
suggest the proper shape of this curve. Our probit model fits the monotonicity requirement
however it is not unique in doing so. To examine the robustness to misspecification of the missing
data mechanism we compare estimation results from three different missing data mechanisms; a
linear model within a probit function, a quadratic model within a probit function and a linear
model within a logit function. Data was simulated 100 times and for each data set a different set
of missing values was simulated according to the three different models. Simulation parameters
were selected so that the overall percentage of missing values would be near 33%. As pictured
in Figure 3.12, the results suggest that the M5 model is fairly robust to misspecification of the
missing data mechanism. Amongst matched proteins the worst case scenario occurred when the
real mechanism was a logit model. In this case the average MSE increased by 8% from .26 to .28,
which is still 20% lower than the MSE for the method of medians found in the simulation study.
Misspecification from a quadratic model actually reduced the average MSE by 10%. These results
seem to suggest that sharper the increase in the probability of observing a peptide the better
our model will perform. For one-sided and unmatched proteins the effects of misspecification
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Figure 3.12: MSE computed from 100 simulations utilizing 3 different missing data mechanisms.
were more pronounced. For one-sided proteins we observed a 42% increase in average MSE
with a probit misspecification and a 34% decrease for the quadratic model. For unmatched
proteins these changes were 43% and -53% respectively. The increased effect of the missing data
mechanism for these proteins should not be surprising since the mechanism plays a larger role in
the estimation when no matched pairs are observed. In the worst case scenario the average MSE
for a one-sided Protein from a logit missing data model was 3.87. With a range of fold changes
in the data from roughly -10 to 10 an MSE of 3.87 is highly encouraging as it suggests that even
with misspecification the M5 model provides a legitimate way to detect one-sided proteins with
large fold changes.
3.5 Conclusion
We have identified the two fundamental statistical features of mass spectrometry proteomics
as matched pairs data and non-ignorable missingness. Of the two features, ignoring matched pairs
appears to be far more detrimental than ignoring the missing data bias. Not only is the average
intensity across peptides difficult to interpret, but the simple method of taking the median ratio
greatly outperforms methods based on average intensities in terms of mean squared error. In
turn, relative to the method of medians, our M5 model is capable of improving both the depth
and accuracy of the mass spectrometry experiment. To the best of our knowledge, this is the first
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model that provides reliable estimation of one-sided proteins and our experiments and sensitivity
analysis suggests that these estimates could be valuable even when the missing data mechanism
has been misspecified. A great deal of work can be done to extend this model. Here we have only
demonstrated the importance of peptide level matching with a model that compares two samples
from either a SILAC or LFQ experiment. A different missing data mechanism would be required
to fit iTRAQ data and extensions for multiple sample comparisons and sample fractionation are
not immediately obvious. In whatever way these more complicated problems might be solved, the
lessons from this study should be incorporated into the solution. The joint presence of matched
pairs data and non-ignorable missingness can greatly inflate the error in estimation procedures
that do not explicitly account for both features.
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CHAPTER 4: EXTENDING BEYOND THE TWO SAMPLE EXPERIMENT
4.1 Introduction
Mass spectrometry proteomics experiments are often referred to as relative quantification
experiments. This is because the technology only enables inference to the ratio of protein abun-
dances without ever obtaining measures of absolute abundance. Even in the most basic case,
where two samples are being compared, variations in ionization efficiency and widespread miss-
ing data can substantially complicate the task of creating a formal statistical model. In the
previous chapters potential solutions to these complications were discussed. However, modeling
is further complicated by experiments that contain multiple samples and replicate data. If there
are K samples to be compared then there are K choose 2 ratios that can be estimated which can
be a source of confusion for statisticians attempting to model proteomics data. In this chapter
we propose models for iTRAQ and SILAC experiments which account for ionization efficiency,
missing data and which apply to arbitrary numbers of samples and replicates. Understanding the
motivation for our model requires explanations of ionization efficiency and the nature of missing
data in a mass spectrometry experiment.
4.1.1 Model construction
The factors in our experiment are protein, peptide within protein, sample and run. Suppose
that we have i = 1, ..., I proteins, j(i) = 1, ..., Ji peptides within each protein, k = 1, ...,K samples
to compare and l = 1, ..., L runs. Then for a given peptide the number of molecules in a sample
should depend on the sample the peptide and possibly some systematic experimental deviations
in the form of a run effect. The obvious model for mean peptide molecule abundance is given by
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E(aijkl) = β0 + αi + βj(i) + γk + δl + αγik.
However these variables are not the same as those that affect ionization efficiency. In both
SILAC and iTRAQ experiments we have good reason to believe that the ionization efficiency for
a peptide will be the same across samples, since they are all ionized under the same conditions.
However, the efficiency can vary dramatically from run to run. Richard Knochenmuss convinc-
ingly demonstrates that when using Matrix Assisted Laser Desorption/Ionization (MALDI), the
most common ionization technology used in iTRAQ experiments, by simply altering the amount of
sample processed the rank order of the intensities measured can be completely reversed (Knochen-
muss, 2012). He ascribes this behavior to the complicated nature of electrons transfers that occur
in the ion plume. Essentially, the factors that determine ionization efficiency are highly multi-
variate and for the most part unobserved. Furthermore, these unobserved factors are bound to
change when experiments are replicated because the background analytes (other chemical struc-
tures that are ionized at the same time as a target peptide) will always change due to variations
in the elution process. The result is a large amount of variation in peptide level intensities that
we would greatly like to remove from our estimation procedure. Schliekelman and Liu (2014)
estimated that the effect of background peptides on the probability that a peptide would be ob-
served in a sample exceeded the effect of the abundance of a peptide molecule. For these reasons
we have addressed the modeling problem assuming that an interaction term will be needed. If
for a particular sample a researcher believes that no background interferences will occur then it
will be simple to remove the interaction from our model. This leads us to the following model
for the expected ionization efficiency.
E(piijkl) = β
∗
0 + β
∗
j(i) + δ
∗
l + βδj(i)l.
Thus a model for the intensities we actually can observe would be given by
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E(yijkl) = E(aijkl + piijkl) = (β0 + β
∗
0) + αi + (βj(i) + β
∗
j(i)) + γk + (δl + δ
∗
l ) + αγik + βδj(i)l.
Notice that in this model, though many parameters can only be interpreted as a combination
of ionization and abundance effects, the contrast between two samples k and k′ with all other
factors fixed, (γk+αγik−γk′ +αγik′), only contains parameters from the abundance model. Thus,
even though we only make observations on the number of ions that enter a mass spectrometer,
estimating between sample contrasts still provides a way to make inference on the original sample.
For this reason we consider the contrasts to be the parameters of interest.
Without explicitly modeling ionization efficiency other researchers have created similar models
for proteomics data (Oberg and Vitek, 2009). There are two substantial features that set apart
our approach. The first obvious difference is the inclusion of an interaction between peptide and
run. Without this all of the variations in ionization efficiency will greatly inflate the error term.
The importance of variations in ionization efficiency across runs has not been well studied and
may very well depend on the sample being examined. Of course, if a researcher feels certain
that no peptide by run interaction will be present, removing the term from the model causes
no difficulties. The second major difference is that our model provides a clear explanation of
the special role contrasts play in a mass spectrometry proteomics experiment. Without our
explicit modeling of ionization efficiency there would be nothing in the model to suggest that
the experiment was only intended to estimate absolute abundance. With this model established
as a general framework for mass spectrometry proteomics experiments we can now consider the
effects of missing data.
4.1.2 Categories of Missing Data
One of many characteristics of a proteomics experiment, which makes it difficult to apply
standard statistical methods, is the lack of a priori knowledge about what data will be observed
in the experiment. In the terminology of our model, we don’t know the values of I or Ji. This
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creates some ambiguity when discussing missing data. If we have one row in our data set for each
observed peptide there are many ways we could expand the number of rows to contain missing
values. The simplest solution is to use a complete case analysis and not expand the rows at all.
However as we showed in chapter 3, substantial gains in accuracy and depth of discovery can be
made by making use of missing data patterns. However, only two samples were being compared
and there were no replicates so it seemed fairly straightforward to establish the definition of a
missing value. We now consider more possibilities. At the opposite extreme from a complete
case analysis we can consider the all possible peptides model. Since we know how proteins should
fragment into peptides we can create lists of all possible peptides based on the complete amino
acid sequence of the identified proteins. Thus for every protein observed, rows would be added to
the dataset for all possible peptides in every sample and run. This would be a complete expansion
of row space to all possible peptide outcomes and consequently if there is any useful information
in the missing data patterns, the full expansion would contain it. It is at least conceivable that
information on the proportion of an amino acid sequence that manifested into observed peptide
intensities could be useful in assessing the variability of our estimates. However, to the best of our
knowledge nobody has attempted to analyze all possible peptide expansions. This is likely due to
the difficulty of the task as it would require a good deal of database searching and computation
just to figure out what rows of missing data should be included in the model. Once included,
it is also not clear how much would be gained by the effort. Many of the peptides that were
not observed might have had chemical properties such that ionization could not possibly have
occurred. Should a researcher consider a data point that could not have conceivably appeared to
be missing? If there is a reason to do so it is not immediately obvious. At least three possibilities
exist in between the complete case analysis and an all possible peptides model. We seek to clarify
the problem of including missing values by classifying peptides into five different levels, shown in
table 4.1.
Level zero is the complete case analysis where only peptides that are observed are included in
the statistical model and level four is the all possible peptide model. For level one we introduce the
concept of verifiably sufficient ionization efficiency. A peptide has sufficient ionization efficiency
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Table 4.1: Different levels of missing data that could be accounted for in a statistical model.
Missingness Level Intensities included in model
Level 4 All possible intensities
Level 3 Intensities for all peptides ever shown to be ionizable
Level 2 Intensities for all peptides shown to be ionizable in the data
Level 1 Intensities with verifiably sufficient ionization efficiency
Level 0 All intensities observed in the data
if the probability of ionization is high enough to conceivably enable the observation of a peptide
intensity. Recall that ionization efficiency is a property of not only the peptide but also the
background analytes and ultimately the experimental run. We say that a peptide has verifiably
sufficient ionization efficiency if the dataset contains any instances of a peptide being observed
within a specific run. In other words we know that the ionization efficiency, created by the
amino acid sequence and the specific experimental conditions, was not so low as to prevent all
observations of the peptide intensity. In terms of the parameter in our model this means that we
only include midpoints where at least one of the samples was observed. Level 1 is a subset of level
2, which contains all intensities belonging to peptides which we know could have ionized due to
their presence somewhere in the dataset. To clarify the difference, suppose that in an experiment
with 4 samples and 2 replicates for peptide j(i) we observe only yj(i),1,1 and yj(i),2,1. Then using
level 1 missingness our model would include peptides yj(i),1,1, yj(i),2,1, yj(i),3,1, yj(i),4,1 where the
peptides from samples 3 and 4 are missing. Using level 2 missingness our model would include
yj(i),1,1, yj(i),2,1, yj(i),3,1, yj(i),2,1, yj(i),1,2, yj(i),2,2, yj(i),3,2, yj(i),4,2 adding missing values for all of the
peptides that theoretically could have appeared in run 2. In terms of our model, level 1 can be
understood as only using midpoints for which at least one data point exists. Level 2 includes all
peptides that we know, without considering variations in ionization efficiency, could have been
ionized because they were observed at some point in our experiment. If a researcher thinks this is
reasonable it is difficult to see why we would stop here. Level 3 is defined to include all intensities
belonging to peptides that we have knowledge of being ionizable. This would require information
outside of the experiment and it is not immediately obvious how to compile such information
but in theory the proteomics literature already contains a tremendous amount of information
regarding what amino acid sequences are capable of being ionized with various technologies. The
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final all inclusive step is level 4 which contains all of the possible intensities from every possible
peptide sequence within each identified protein. We cannot rule out the possibility that methods
which utilize level 4 missingness would be optimal, however there is a tradeoff because as the
missingness level increases so do the potential sources of missingness.
4.2 Missing Data Mechanisms
Previously we gave a detailed explanation of the causes of missing data in a mass spectrometry
proteomics experiment. The causes are numerous and identifying the direct cause for any partic-
ular peptide is a hopeless endeavor. However, we have good reason to believe that the probability
of observing an intensity will be a monotone increasing function of the intensity itself. For this
reason we fit a probit missingness model such that the probability of observing an intensity, y, is
given by Φ(a+ by) where Φ is the standard normal CDF, and a and b are missingness parameters
to be estimated in our analysis. This missingness mechanism is really an approximation of what
we expect to happen when the many different sources of missing data are consider in aggregate.
For multi-sample SILAC experiments the same missing data mechanism should be useful. How-
ever, the justifications for this mechanism do not apply to iTRAQ experiments. We previously
identified an ever changing detection limit, and data dependent analysis, as the two major sources
of non-ignorable missingness. Essentially an intensity needs to be sufficiently large to be selected
by the operational software for the tandem step of a mass spectrometry experiment. In either a
SILAC or a LFQ experiment this tandem step is solely used to identify the peptide. In an iTRAQ
experiment all of the quantification also occurs during the tandem step. Critically, isobaric tags
do not alter the mass of the peptides from different samples. Thus the intensity from the first MS
step is actually a reading of the sum of the intensities across samples. Consequently, we should
not expect the probability of missingness to be dependent on an individual peptide y, rather it
should be dependent on the sum of intensities across samples. Furthermore, if a given peptide
is not selected for tandem mass spectrometry in an iTRAQ experiment then that peptide will
be missing in all of the samples. If we only consider Level 1 missing data then intensities that
are missing because they were not selected for tandem mass spectrometer will not appear in our
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data, not even as missing values. This begs for a re-evaluation of what might cause values to
appear as missing in a Level 1 missing data iTRAQ experiment. In this case we have observed
at least one peptide intensity while the same peptide from the same run was not observed in at
least one of the other samples. At this stage of the experiment we know exactly where the mass
of the isobaric tag should be located. We also know that the identification went well since the
peptide was identified in another sample. It seems likely that any missing values in this situation
are legitimately missing because they fell below the instruments detection limit. In this case, we
prefer to take the conservative approach and impute the minimum intensity found in the data
set.
To extend our previous work we would like to create extended versions of M3 and M5 for both
ms1 and ms2 types of data. Taking the model framework described in this chapter and fitting it
with a mixed model will serve as an M3 type estimation for both ms1 and ms2 data. This model
will essentially ignore all missing values, but since we are obtaining random effects predictors
even the missing proteins will have estimates taken from the overall parameter distributions. In
order to extend M5 the full conditional distributions must be derived in order to fit the Gibbs
sampler. In particular we find that the distribution for any of the mean parameters in our model
is given by
(α|·) ∼ N
(
σβα + τ
∑I
j=i(yj −Xθ∗[j])
σ + τI
,
τσ
σ + τI
)
and that the distribution of a missing value given everything else, for an ms2 technology follows
the skew normal distribution
f(Ym|·)(x) =
φ(x−µx√
σ
)Φ(ω
√
1 + (−b√σ)2 − b√σ(x−µx√
σ
))
√
σΦ(ω)
=
φ(x−µx√
σ
)Φ(−a− b∑nj=i yj − bx)√
σΦ(ω)
.
Derivations of these distributions can be found in Appendix A.1. With these derivations
completed, all of the machinery is in place to analyze data from more complicated proteomics
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experiments.
4.3 Discussion
We have established new categories for missing data, and created extensions to M3 and M5
for both ms1 and ms2 data. However, for every step we take a dozen questions appear. The
most obvious question is whether or not there is any value in utilizing Level 2 missing data. We
have already demonstrated that Level 1 missing data can be used to improve the accuracy of
point estimation and increase the depth of discovery so we expect to find similar results when
comparing results from the extensions of M3 and M5 that utilize ms1 missing data. However, it
is unclear if the same benefits will be found when using level 2 missing data. This is of particular
importance when analyzing ms2 data, where no level 1 missing data exists. This also suggests
an obvious way to explore the potential benefit. We construct a simulation experiment where for
every data set simulated a set of ms1 and a set of ms2 missing data vectors are generated using
either a probit on an individual intensity or on the sum of intensities across samples, respectively.
We will then fit the m3 and m5 extensions for both ms1 and ms2 data (four models are fit for
each simulated dataset). Boxplots of the simulated mean squared errors are shown in Fig 4.1.
The average MSE across 100 simulations for the M3 model with ms1 missingness was 1.46.
The MSE for the M5 model on the same data was 64% lower at .64. Thus the simulations confirm
that accuracy can be improved by utilizing missing data patterns in the extended ms1 model.
However, the same gains are not seen with the ms2 data. In fact using the ms2 M5 model we
obtained an average MSE of .69 which is actually an increase of 23% over the average MSE for
M3 of .56. This suggests that using level 2 missing data is not very helpful in regards to point
estimation, at least not in the ms2 data. Such a finding might be considered disheartening but
there are benefits to knowing that we can safely ignore level 2 missing data in iTRAQ experiments.
For very large studies, keeping track of level 2 missing data results in enormous and sparse data
sets. Being confident that we are not losing anything by removing this category of missing value
from the data could save a lot of computational effort. This one simulation study should not
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Figure 4.1: Boxplots of the MSE from M3 and M5 models applied to both ms1 and ms2 datasets.
The y axis was cutoff at 1 to preserve resolution of the boxplots.
be considered conclusive regarding the usefulness of level 2 missing data. It is possible that
the missing values while being unhelpful in point estimation could improve interval estimation.
Studies on real data and further simulations regarding the point estimation result would also be
nice. However, these studies will be topics for future research.
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CHAPTER 5: CLUSTERING INDICES
The task of assessing the quality of a clustering algorithm cannot be addressed in a sensible
manner without first understanding the objective of clustering. Unfortunately, there is no clear
consensus on how this problem should be defined. A review paper by Jain (2010) described clus-
tering as an ill-posed problem. The basic idea is to partition a set of points into “similar” groups.
However, the notion of “similar” is completely subjective. This has led to the development of
literally thousands of clustering algorithms, and even minor alterations to these algorithms can
result in substantially different clusterings of the same dataset (Jain, 2010). From a statistical
perspective, one which includes randomness, it makes sense to define clustering in terms of model
parameters. To this end, a large literature has been created on the subject of model based clus-
tering (McLachlan and Basford, 1987). However, we find that model based clustering has largely
oversimplified the task of data clustering by reducing the objective to a classification problem. We
will demonstrate that even when given the true model for data generation; classification, cluster-
ing and linkage detection pose three distinct estimation problems whose solutions do not always
overlap. After clarifying these concepts we propose new indices of clustering performance which
assess algorithmic performance in terms of sensitivity and specificity. Finally we will demonstrate
the advantages of our indices on a variety of simulated and real world situations.
5.1 The Model
We assume that (Xi, Ai), i = 1, · · · , n are iid random vectors where Xi is a p dimensional
vector and Ai takes values in {1, · · · , G}. The variate Ai is the unobserved subgroup identifier,
and there are G subgroups in the population. The subgroup probabilities are pig := P (Ai =
g), g = 1, · · · , G, where 0 < pig < 1,
∑G
g=1 pig = 1. Let fg(·) be the pdf of Xi conditional on
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{Ai = g}, g = 1, · · · , G. Although it is possible to consider discrete and mixed-type distributions,
we assume for simplicity that the cdf’s are all continuous with corresponding densities {fg }. To
avoid trivialities we assume that the G cdf’s are all distinct. This is clearly a mixture formulation
(McLachlan and Basford, 1987), but it is not restrictive since any distribution can be expressed
as a mixture. We note that the supports of the densities f1, · · · , fG need not be distinct and
generally will overlap or be the same (as in normal mixtures).
The model parameters are: (pi1, · · · , piG, f1, · · · , fG). The densities can be parametric or
non-parametric.
It is worth noting that without specifying the form of the mixture densities, the value of G
is completely arbitrary. For example, with p = 1, and X1, · · · , Xn iid normal(0,1), it may seem
that G = 1. That is a reasonable choice, but other choices are possible. We can define G to
be 2 by expressing the normal(0,1) as a 50:50 mixture of a half normal over x > 0 and another
(mirror image) half-normal over x < 0. A half-normal is obtained from a normal by restricting
the range of x to be above the mean or below the mean. Indeed, we can define G to be any
positive integer we wish by partitioning the real line into G disjoint sets, and defining the jth
mixture component to be a normal(0,1) restricted to the jth set in the partition. However, in
this example, specifying that the mixture components are normal, forces the choice G = 1. This
shows that without adequate specification of the mixture components, the very definition of G
can be problematic.
With the clustering model in place we can now investigate the nature of the clustering problem
from a statistical perspective. Given the true model there are various possibilities for what a
researcher might be interested in studying.
Possibilities include:
1) The grouping of the n sample observations into mutually-exclusive sets. This is essentially
the definition of clustering.
2) Estimation of G, if it is (considered) unknown.
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3) The estimation of pi and f1, · · · , fg.
4) Classifying a future observation Xn+1 into one of the detected clusters. (Without repeating
the whole clustering procedure on the n+ 1 observations).
We focus on defining indices of clustering performance for 1 and 4 above.
5.1.1 Classification
With a known or hypothesized model for the data, the grouping of the n sample observations
into mutually-exclusive sets is usually reduced to the task of assigning labels 1, · · · , G to each of
the observations. Since in practice, the fi’s are unknown, there will be no clear 1:1 correspondence
between population subgroups and label assignments identified in the sample. This has important
implications regarding the assessment of clustering performance as we cannot compute a misclas-
sification rate without knowing to which subgroups our assigned labels corresponds. Nonetheless,
we can make use of some powerful results from the classification literature. In particular, when
the fi’s are known (or hypothesized), the strategy which minimizes the misclassification rate is to
calculate the posterior probabilities of each subgroup and assign a label, to whichever subgroup
has the highest posterior probability (Seber, 2009, chap. 6). This strategy is the foundation
for almost all of the model based clustering methods currently in use and we will refer to this
method as the “optimal classifier”. When all model parameters are known, the optimal classifier
is the one that assigns an observation xi to label k with the largest posterior probability, i.e.
gˆi = gˆ(xi) = k. if P (Ai = k|xi) > P (Ai = j|xi), j 6= k. We assume no ties, which is realistic
for continuous variables. It should be noted that this classification procedure is distinct from
a clustering procedure, since a clustering procedure does not necessarily provide meaningful la-
bels. Clustering is defined as the formation of mutually-exclusive sets of observations, and the
estimation of subgroup labels is not required to achieve this goal.
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5.1.2 Clustering
We define a clustering as a partition of a dataset into mutually-exclusive groups, and we
refer to each mutually-exclusive group as a cluster. It should be noted that any classifica-
tion will induce a clustering, but clusterings do not imply classifications. For example in a
model with 4 subgroups, the classification of X1, · · · , X5, given by Aˆ = (1, 1, 3, 4, 3), implies
the clustering {{X1, X2}{X3, X5}{X4}}. Yet, the converse does not hold as the clustering
{{X1, X2}{X3, X5}{X4}} could have been generated from 4 ∗ 3 ∗ 2 = 24 different sets of la-
bels. It should be observed that since any set of labels induces a clustering the true labels also
induce a true clustering. The partition P induced by A1, · · · , An is obviously a random event,
so the clustering of the n observations is a prediction problem. The aim is to predict P , not
A1, · · · , An. This is a discrete problem of very high dimension. The number of possible partitions
of a set of n elements grows very quickly with n. For n = 5, there are 52 possible partitions (the
Bell number B5 = 52) of a set of 5 items. Though the differences between clustering and clas-
sification are clear, we can re-frame the clustering problem into a classification problem. While
initially we sought to assign labels 1, · · · , G to each of the observations we could alternatively
assign a label, which looks like a set theoretical partition, to the entire vector of observations. The
only reason to conceptualize the problem in this way is to make use of the previously mentioned
theory regarding the minimization of the misclassification rate. For n = 5, each of the 52 possible
partitions has its own posterior probability and selecting the partition with the highest posterior
probability will minimize the probability of misclassifying the clustering. We will refer to this as
the “optimal clustering”. For the case when G=2 there are always two label sets that would in-
duce the same partition. For example with 5 variables x1, ..., x5 and cluster assignments k1, ..., k5
where k ∈ [1, 2]. The classifications (1, 1, 1, 2, 2) and (2, 2, 2, 1, 1) are the only two classifications
that induce the partition {{x1, x2, x3}{x4, x5}}.
Let pii,j be the posterior probability that the ith data point, i ∈ [1 : n], came from the jth
component.
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Table 5.1: The posterior probabilities for a counterexample to the claim that optimal clustering
is equivalent to the clustering induced by the optimal classifier.
G1 G2 G3
x1 0.4 0.3 0.3
x2 0.4 0.3 0.3
Then, in this example the probability of partition {{x1, x2, x3}{x4, x5}} is given by
pi1,1pi2,1pi3,1pi4,2pi5,2 + pi1,2pi2,2pi3,2pi4,1pi5,1
A proof that the optimal clustering is equivalent to the optimal classifier when G = 2 can
be found in appendixB.2. However a simple counterexample demonstrates that this relationship
does not necessarily hold for G > 2 Let G=3 and let the posterior probabilities be described
in Table 5.1. Then the optimal classification is (1, 1) which induces the partition {{x1, x2}}.
However three different classifications could have created this partition so the probability of the
clustering is given by p({{x1, x2}}) = .4∗.4+.3∗.3+.3∗.3 = .34. The only other possible partition
is the singleton partition, {{x1}, {x2}}, which could have come from any of six clusters, resulting
in a posterior partition probability p({{x1, x2}}) = .4∗.3+.4∗.3+.3∗.4+.3∗.3+.3∗.4+.3∗.3 = .66.
Thus, in general, we have shown that the clustering induced by the optimal classifier does not
equal the optimal clustering. This suggests that researchers should give careful consideration to
whether their primary objective is truly clustering or classification, or something else entirely. In
any case, when f1, · · · , fg are unknown neither the optimal classifier or the optimal clustering
can be computed. Furthermore, the misclassification rate, regardless of what is being classified,
also remains beyond our reach. In the absence of a 1-1 correspondence between subgroups and
clusters the only way to analyze the efficacy of a clustering algorithm is to study the comparative
patterns of which variables were and were not linked together. This is typically done by comparing
pairwise linkage.
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5.2 The optimal linkage detector
First we will define optimal link detection and then we will discuss its relationship to the
optimal classifier and to clustering.
Suppose that we try to predict linkage between Xi and Xj , i 6= j, defined as Lij := I(Ai = Aj),
based on observed values xi and xj , and we denote the 0/1 predictor by Lˆij , implicitly a function
of xi, xj and model parameters. Declaring linkage (Lˆij = 1) if the classifiers are equivalent,
gˆi = gˆi, is a possible approach, but it may not be the best approach. Considering 0/1 to
be a label we could once again utilize posterior probabilities to minimize the misclassification
error. The optimal linkage detector is Lˆij = 1 if P (Ai = Aj |xi, xj) ≥ 0.5, and Lˆij = 0 if
P (Ai = Aj |xi, xj) < 0.5. That is, it assigns to Lˆij the value with the largest posterior probability.
Note that P (Ai = Aj |xi, xj) =
∑G
g=1 P (Ai = Aj = g|xi, xj) =
∑G
g=1 P (Ai = g|xi)P (Aj = g|xj),
since (Xi, Ai) is independent of (Aj , Xj) for i 6= j.
It is worth observing that every classification implies a clustering and every clustering implies
a linkage matrix L. This suggests that there might be some relationship between the optimal
classification, the optimal clustering and the optimal linkage matrix. We have already shown
that the optimal classification is not necessarily equivalent to the optimal clustering. We now
show that the optimal linkage detector and the optimal classifier are not the same and produce
different Lˆij , except in the case G = 2.
To see that the optimal linkage detector and the optimal classifier are not the same, consider
the case G = 3, and suppose P (Ai = 1|xi) = P (Aj = 1|xj) = 1/2, P (Ai = k|xi) = P (Aj =
k|xj) = 1/4 for k = 2, 3. Now, P (Ai = Aj |xi, xj) = 3/8 and the optimal detector assigns Lˆij = 0.
However, the optimal classifier puts both observations in cluster 1 and hence assigns Lˆij = 1.
In the case G = 2, let a = P (Ai = 1|xi) and b = P (Aj = 1|xj). If both a, b ≥ 1/2
then gˆi = gˆj = 1. If both a, b < 1/2 then gˆi = gˆj = 2. In both cases, P (Ai = Aj |xi, xj) =
ab+ (1− a)(1− b) > 1/2, and the optimal linkage detector will assign Lˆij = 1. It is also easy to
verify that if a < 1/2 < b or b < 1/2 < a, then gˆi 6= gˆj and Lˆij = 0. Hence, it is only for G = 2
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Table 5.2: The posterior probabilities for a counterexample to the claim that the optimal linkage
matrix, when it forms a partition, is equivalent to the linkage matrix induced by the optimal
clustering.
G1 G2 G3
x1 0.40 0.31 0.29
x2 0.67 0.15 0.18
x3 0.15 0.70 0.15
x4 0.18 0.70 0.12
x5 0.75 0.13 0.12
that the optimal classifier is also the optimal linkage detector.
A classifier can be used for clustering since it creates a partition. A linkage detector by itself is
not sufficient since the (n2 ) links, Lˆij , generally do not define a partition (consider Lˆ12 = 1, Lˆ23 =
1, Lˆ13 = 0). In this setting another procedure would be needed to convert the linkage matrix
into a partition. Furthermore, even when a linkage matrix does correspond to a partition, the
optimal clustering still does not have to be equivalent to the optimal linkage matrix. For a counter
example consider the case where G = 3, n = 5 and the posterior probability matrix is given in
Table 5.2. In this case it can be seen, with a bit of help from a computer, that the linkage matrix
induced by the optimal clustering is defined by 1001001100, where each number from left to right
represents the strictly lower triangular entries of the matrix. However, the optimal linkage matrix
is defined by 0000001100.
Thus we have established that clustering, classification, and linkage identification are three
inherently different tasks, so even when the model is known and optimal procedures are available
it might not be clear which strategy to use. On the other hand, it is conceivable that just being
aware of these differences could help a researcher to determine an appropriate strategy for their
particular application. For clustering, the distinction between pairwise linkage optimization and
clustering optimization is particularly interesting because the standard methods for evaluating
cluster performance are all based on pairwise linkage.
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5.3 Clustering Indices
Substantial efforts have been made to assess the comparative strength of clustering algorithms
by proposing indices that measure the similarity of two clusterings. Such indices take on a special
meaning when one of the clusterings represents the true subgroups. Often clustering algorithms
will be tested in simulations or other settings where the true subgroups are known and an index
will be used to compare the results. The most commonly used is the Rand index (Rand, 1971)
which is calculated as the number of pairs that were linked together in both clusterings, plus
the pairs that were not grouped together in either clustering, all divided by the total number
of possible pairs. The result of this computation is a number between zero and one, where a
one implies perfect pairwise alignment between the clusterings and a zero represents complete
disagreement. Intuitively this index seems to be capturing some form of agreement. However,
the Rand index does not stand alone. In a paper by Albatineh et al. (2006) 28 different indices,
all based on pairwise comparisons, for comparing two cluster assignments were identified. Al-
though researchers have been using such indices since at least 1971 very few arguments exist to
convincingly demonstrate why any one of these indices should be preferable to another. An effort
made to evaluate these indices by Arbelaitz et al. (2013) attempted to find the top performing
cluster index through extensive simulations. They analyzed 30 cluster indices under 6,480 config-
urations of clustering methods and data generation combinations. They decided to measure the
success of a validity index by the frequency with which the index achieved its highest value, when
the selected number of clusters coincided with the true number of groups from the simulations.
Rather unsurprisingly, they found that the rank order of performance changed depending on the
settings in a complicated multivariate way. The notion that optimal performance should occur
when the number of specified clusters corresponds to the number of underlying subgroups is what
we call the K = G conjecture and it is something we will explore throughout the examples in
this paper. Rather than assume that optimal performance will occur when K = G we prefer to
create a mathematical framework for the indices with a desirable probabilistic interpretation.
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5.4 Clustering Sensitivity and Specificity
Here we define indices of clustering performance. For reasons previously discussed performance
can’t be based on knowing the true cluster status. The reason is not only that the true status
is unknown, but also, the lack of 1:1 correspondence mentioned above. Performance measures
should not require knowing G, since in practice G is either fixed at some value, or estimated from
the data. We define indices that satisfy the above criteria. Consider two independent random
vectors (Xi, Ai) and (Xj , Aj), and define gˆi and gˆj to be their respective cluster id assignments
given by a clustering procedure. If the ith and jth observations belong to the same subgroup,
Ai = Aj , we say that they are linked. If we view the clustering problem as a problem of detecting
links between observations, we can use measures from the diagnostic testing literature to describe
the performance of diagnostic tests. That is, we view a clustering procedure as a diagnostic test;
the test for linkage between the ith and jth observations is positive if gˆi = gˆj and negative if
gˆi 6= gˆj . The true linkage status between the two observations is positive if Ai = Aj and negative
if Ai 6= Aj . Of course, in diagnostic testing studies, the true status is known, but in clustering
applications it is unknown except in simulation experiments.
Now the proposed criteria are defined.
Clustering sensitivity (CSENS):
κ1 := P (gˆi = gˆj |Ai = Aj).
Clustering specificity (CSPEC):
κ2 := P (gˆi 6= gˆj |Ai 6= Aj).
Clustering positive predictive value (CPPV):
κ3 := P (Ai = Aj |gˆi = gˆj).
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Clustering negative predictive value (CNPV):
κ4 := P (Ai 6= Aj |gˆi 6= gˆj).
The CSENS measures how well observations from the same cluster are clustered together
by a second procedure. The CSPEC measures how well observations from different clusters are
actually assigned to different clusters in a second procedure. CSENS and CSPEC measure the
ability of the procedure to detect linkage and non-linkage. On the other hand, the CPPV and
CNPV measure the strength of the detected linkage or non-linkage.
The indices {κj : j = 1, 2, 3, 4} must be taken together as a measure of performance; one index
alone is not sufficient. We can easily get CSENS = 1 by placing all observations into one cluster.
But that would lead to CSPEC=0. This situation is analogous to sensitivity and specificity of
diagnostic tests; we can’t improve one without compromising the other.
A useful property of these indices is that they do not require the true number of clusters G
to be known, and do not require the chosen number K, whether fixed or estimated, to be equal
to G.
Another point to note is that these indices can (in principle) be computed for any clustering
procedure and given model when all the parameters are known. In comparing various clustering
methods we start with a statistical model for the problem of interest. Then we can assess the
difficulty of the problem under various assumptions and parameter values. The indices can
also be used to compare the performance of different clustering methods under one given model
or under various models. We give two simple examples where the optimal index values can be
evaluated theoretically. For more general models and arbitrary clustering algorithms, a numerical
approximation can be obtained via simulation.
The optimal values, the indices that occur when using either the optimal clustering or the
optimal classifier, are an upper bound on the precision of any clustering algorithm and hence
measure the “difficulty” of the clustering problem. An example of a difficult clustering task is
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a mixture of two very similar distributions, e.g. a 50:50 mixture of a N(0, 1) and a N(10−6, 1).
Under this model, no clustering procedure is expected to do well with any realistic amount of
data. On the other hand the task of clustering a 50:50 mixture of a N(0, 1) and a N(10, 1)
is an easy problem. Closeness of the mixture components to each other and very small mixing
probabilities both tend to make the problem more difficult. However, there are situations where
the picture is not so clear, and where indices can help assess the problem. The proposed indices
help in quantifying the difficulty level inherent in a given model with given parameter values.
The above examples show that the number of groupings that we wish to look at varies almost
completely with the underlying population model. However in those examples each grouping was
at least compact to some extent. We can also give examples where the optimal clustering does
not involve compact sets. Thinking about the underlying structure of the data at a population
level will clearly alter the interpretation of a clustering algorithm, but given an assumed or known
structure we need to determine how well a clustering algorithm is working.
Now we give general expressions for the indices. Let pig = P (Ai = g), g = 1, · · · , G, and
let pi denote the column vector (pi1, · · · , piG)>. Of course,
∑G
g=1 pig = 1. Next, we compute the
probabilities of relevant events.
For two independent observations, say observations 1 and 2, P (A1 = A2) =
∑G
g=1 pi
2
g = pi
>pi =
ssq(pi), ssq denotes the sum of squares.
Define bgj = P (gˆi = j|Ai = g) for g = 1, · · · , G; j = 1, · · · , k. The bgj ’s are collected into the
G×K matrix B.
The marginal distribution of gˆi is given by
P (gˆ1 = j) =
G∑
g=1
P (A1 = g)P (gˆ1 = j|A1 = g)
=
G∑
g=1
pigbgj = (B
>pi)j .
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Table 5.3: The 2× 2 table of probabilities used to compute the clustering indices.
gˆ1 6= gˆ2 gˆ1 = gˆ2 Total
A1 6= A2 γ1 γ2 1− ssq(pi)
A1 = A2 γ3 γ4 = trace(C
>C) ssq(pi)
Total 1− ssq(B>pi) ssq(B>pi) 1
That is, the K-vector B>pi is the pmf of gˆi, and
P (gˆ1 = gˆ2) = pi
>BB>pi = ssq(B>pi).
The joint probability of true linkage and its detection in a sample is
P (gˆ1 = gˆ2, A1 = A2) =
G∑
g=1
K∑
j=1
P (gˆ1 = gˆ2 = j, A1 = A2 = g)
=
G∑
g=1
K∑
j=1
P (A1 = A2 = g)P (gˆ1 = gˆ2 = j|A1 = A2 = g)
=
G∑
g=1
pig
K∑
j=1
b2gj
= trace(B>diag(pi2g)B)
= trace(C>C),
where C = diag(pig)B.
The relevant probabilities can be displayed in a 2 × 2 table as shown in Table 5.3. Now we
easily obtain
γ2 = ssq(B
>pi)− trace(C>C),
γ3 = ssq(pi)− trace(C>C),
γ1 = 1− ssq(pi)− ssq(B>pi) + trace(C>C),
κ1 = γ4/(γ3 + γ4),
κ2 = γ1/(γ1 + γ2),
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κ3 = γ4/(γ2 + γ4),
κ4 = γ1/(γ1 + γ3).
5.5 Examples
Example 1:
A (pi1, pi2) mixture of a uniform(0,1) and a uniform(δ, δ + 1), with δ ∈ (0, 1). By symmetry, it
suffices to consider pi1 ∈ (0, 0.5]. The optimal classifier is gˆ(xi) = 1 if xi ∈ (0, δ) and gˆ(xi) = 2
otherwise. The indices are computed as follows.
B =
 δ 1− δ
0 1
 ,
ssq(B>pi) = 1− 2pi1δ(1− pi1δ),
pi>pi = ssq(pi) = 1− 2pi1(1− pi1),
trace(C>C) = pi21{1− 2δ(1− δ)}+ pi22,
and the indices are
κ1 =
pi21{1− 2δ(1− δ)}+ pi22
1− 2pi1(1− pi1) ,
κ2 = δ,
κ3 =
pi21{1− 2δ(1− δ)}+ pi22
1− 2pi1δ(1− pi1δ) ,
κ4 =
1− pi1
1− pi1δ .
Example: pi1 = 0.3, δ = 0.5 gives κ1 = 0.922, κ2 = 0.5, κ3 = 0.718, κ4 = 0.824.
Tables demonstrating the relationship between the indices and changes to pi1 and δ can be
found in Appendix C.2. For this example, sensitivity decreases as both pi1 and δ increase, while
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specificity appears to only be a function of δ.
Example 2:
Consider a mixture of two normals; a N(0, 1) with probability pi1 and a N(µ, σ
2) with probability
pi2 = 1 − pi1. The parameters are: (pi1, µ, σ2). Since a linear transformation leaves the problem
essentially unchanged, it suffices to consider µ > 0, σ2 ≥ 1 and pi1 ∈ (0, 1).
Now we derive the optimal classifier, the one which assigns gˆi = gˆ(xi) = 1 if pi1f1(xi) >
pi2f2(xi), and gˆi = 2 otherwise.
We will use φ(., a, b) to denote the pdf of the normal distribution with mean a and variance b,
and Φ() to denote the cdf of the standard normal distribution. We start with the case of σ2 = 1.
Here, gˆ(x) = 1 if µx < log(pi1/pi2) + µ
2/2, which (for µ > 0) gives
b11 = Φ
(
1
µ
log
pi1
pi2
+
µ
2
)
, b21 = Φ
(
1
µ
log
pi1
pi2
− µ
2
)
.
That is, x is assigned to cluster 1 if it is below µ2 +
1
µ log
pi1
pi2
and to cluster 2 otherwise. The
optimal classifier divides the real line into two disjoint sets.
Now we deal with the case σ2 > 1. The ratio
f1(x)
f2(x)
= σ exp
(
µ2
2(σ2 − 1)
)√
2piτ2φ
(
x, θ, τ2
)
has a maximum of
M := σ exp
(
µ2
2(σ2 − 1)
)
.
In the above,
θ :=
−µ
σ2 − 1 , τ
2 :=
σ2
σ2 − 1 .
Note that M > 1 since σ2 > 1. So if M < pi2/pi1 then pi1f1(x) < pi2f2(x) and gˆ(x) = 2 for all
x. This can arise only if pi2 > 1/2. This is an interesting case in which the optimal procedure
assigns all observations to a single cluster, even though the model with two clusters and all its
parameters are completely known. It shows that accurate estimation of G is not a requirement for
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optimal performance of a clustering procedure. A numerical example shows that this is possible:
pi1 = 0.25, µ = 1.5, σ
2 = 4,M = 2.91 < pi2/pi1 = 3.
This model with any combination of parameter values that leads to M < pi2/pi1 has an optimal
procedure with κ1 = 1, κ2 = 0, κ3 = ssq(pi) and κ4 is undefined. The sum κ1 + κ2 is 1, which is
exactly what is expected from a diagnostic test that is of no value. Hence, such parameter values
define what is, in a sense, a most-difficult problem. We emphasize that this applies to only a
subset of the parameter space.
Another example is: pi1 = 0.15, µ = 3, σ
2 = 16,M = 5.40 < pi2/pi1 = 5.67.
Another example is: pi1 = 0.35, µ = 0.1, σ
2 = 1.01,M = 1.66 < pi2/pi1 = 1.86.
Another example is: pi1 = 0.2, µ = 1, σ
2 = 1.5,M =
√
1.5e ≈ 3.329 < pi2/pi1 = 4.
If M ≥ pi2/pi1 then gˆ(x) = 1 if
|x− θ| <
√
2τ2 log
Mpi1
pi2
,
Otherwise, we assign gˆ(x) = 2. That is, x values within
√
2τ2 log Mpi1pi2 from θ are assigned to
cluster 1. More extreme values, above and below θ are assigned to cluster 2. Hence the region
assigned to cluster 2 is a union of two disjoint sets. This shows that the notion that observations
close together should be placed in the same cluster is generally false. This also highlights the need
to define precisely what is meant by a “cluster”, and to not confuse true population subgroups
with estimated sample clusters. Here we define the subgroup of xi to be the mixture component
that generated it, not what “region” the observation is in. Indeed an observation from cluster 1
may fall inside the region assigned by the optimal classifier to cluster 2. This may be a subtle
point, but it bears keeping in mind.
5.5.1 Computing the indices in other models and clustering procedures
The only practical way to compute the indices for more complex models and clustering pro-
cedures is to use simulation. Briefly, we simulate a dataset of n iid observations, apply any
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given clustering algorithm, compute estimates of the indices, repeat a large number of times and
average the estimates.
From each sample we obtain a cross tabulation of the true cluster id versus the assigned
cluster id. This will be a G × K table with entries nij and total n.. = n. From this table we
obtain a 2x2 table that tabulates the true linkage status versus the assigned linkage status.
For each combination, we compute κj , j = 1, 2, 3, 4.
We examine K-means clustering (MacQueen, 1967), Hierarchical Clustering with Average
linkage (Tibshirani et al., 2004, ch. 14) and Model Based Clustering (McLachlan and Basford,
1987) under two sets of parameters. All clustering algorithms were implemented in R 2.15.1.
K-means and Hierarchical Clustering were computed using the base functions kmeans() and
hclust() respectively. Model based clustering was performed with the function normalmixEM()
in the ’mixtools’ package. In all the settings that we will test these algorithms, the true model
is a mixture of two Gaussian random variables where the first component is a N(0, 1) random
variable. Results for a N(0, 1) is mixed evenly with a N(3, 1) are given in Table 5.4.
Table 5.4: The clustering indices are computed for Kmeans, Hierarchical Clustering with Average
Linkage, and model based clustering with different specifications of K the number of clusters.
The true model is a Gaussian mixture model with a N(0, 1) is mixed evenly with a N(3, 1).
K=2 K=3 K=5 K=10
CSENS:Kmeans 0.872 0.584 0.378 0.200
CSENS:HC 0.865 0.729 0.48 0.234
CSENS:MB 0.848 0.815 0.82 0.854
CSPEC:Kmeans 0.871 0.900 0.948 0.977
CSPEC:HC 0.754 0.863 0.928 0.972
CSPEC:MB 0.756 0.443 0.304 0.228
CSENS+SPEC:Kmeans 1.74 1.48 1.33 1.18
CSENS+CSPEC:HC 1.62 1.59 1.41 1.21
CSENS+CSPEC:MB 1.6 1.26 1.12 1.08
CPPV:Kmeans 0.871 0.854 0.879 0.899
CPPV:HC 0.779 0.842 0.87 0.894
CPPV:MB 0.776 0.594 0.541 0.525
CNPV 0.872 0.684 0.604 0.55
CNPV:HC 0.848 0.761 0.641 0.559
CNPV:MB 0.832 0.705 0.628 0.611
In this setting all of the clustering algorithms perform the best, in terms of sensitivity plus
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specificity, when the number of clusters is correctly specified. However, it is worth noting that we
are looking at only a univariate setting where the components are two standard deviations apart
and even correctly setting K = G sensitivity can be as low as .85 and specificity as low as .75.
With other clustering indices, we can only use these values for comparative purposes. However,
with our indices we can take advantage of the probabilistic interpretation to observe that 15% of
the time pairs that should be linked together will not be and 25% of the time pairs that should
not be linked together will be. This means that with a model where statisticians usually expect
to be able to easily detect group differences, with a decent sample size, the problem of assigning
group labels fails fairly often. We will now consider a more difficult setting. We set the second
component equal to a N(1.5, 4) mixed in at a proportion of pi2 = .75. These are the parameter
settings described above that yield an optimal classifier when every sample is assigned to the
same cluster. Unsurprisingly, Table 5.5 none of the methods do well in this configuration. From
the standpoint of correct classification, sensitivity plus specificity is equal to one when simply
guessing at random.
Table 5.5: The clustering indices are computed for Kmeans, Hierarchical Clustering with Average
Linkage, and model based clustering with different specifications of K the number of clusters.
The true model is a Gaussian mixture model where 25% comes from a N(0, 1) and the rest comes
from a N(1.5, 4).
K=2 K=3 K=5 K=10
CSENS:Kmeans 0.54 0.379 0.245 0.121
CSENS:HC 0.788 0.582 0.345 0.16
CSENS:MB 0.719 0.746 0.781 0.82
CSPEC:Kmeans 0.509 0.659 0.787 9×10−1
CSPEC:HC 0.187 0.403 0.669 0.851
CSPEC:MB 0.299 0.289 0.272 0.229
CSENS+SPEC:Kmeans 1.05 1.04 1.03 1.02
CSENS+CSPEC:HC 0.975 0.985 1.01 1.01
CSENS+CSPEC:MB 1.02 1.03 1.05 1.05
CPPV:Kmeans 0.647 0.649 0.657 0.669
CPPV:HC 0.618 0.619 0.635 0.642
CPPV:MB 0.631 0.636 0.641 0.639
CNPV 0.399 0.389 0.385 0.381
CNPV:HC 0.346 0.366 0.38 0.378
CNPV:MB 0.39 0.406 0.427 0.433
The next simulation is from a mixture model with 5 equally proportioned components. Vari-
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ance of each component is one and the means are evenly spaced between 2 and 10. The results
shown in Table 5.6 show that, in terms of sensitivity plus specificity, the optimal classifier provides
the best performance, all methods perform the best when K = G, and even the best performance
still yields a 20% chance of failing to group pairs together that should be and a 5% chance of
grouping together pairs that should not be together.
Table 5.6: The clustering indices are computed for Kmeans, Hierarchical Clustering with Average
Linkage, model based clustering, and the optimal classifier (when applicable), with different
specifications of K the number of clusters. The true model is a 5 component Gaussian mixture
model, with each component evenly proportioned and two standard deviations apart.
K=2 K=3 K=5 K=7 K=10
CSENS:Kmeans 0.911 0.845 0.774 0.595 .439
CSENS:HC 0.944 0.885 0.777 0.646 .485
CSENS:MB 0.941 0.871 0.762 0.672 .548
CSENS:Opt 0.808
CSPEC:Kmeans 0.601 0.791 0.94 0.96 .974
CSPEC:HC 0.585 0.769 0.921 0.951 .971
CSPEC:MB 0.507 0.69 0.832 0.903 .941
CSPEC:Opt 0.952
CSENS+SPEC:Kmeans 1.51 1.64 1.71 1.55 1.41
CSENS+CSPEC:HC 1.53 1.65 1.7 1.6 1.46
CSENS+CSPEC:MB 1.45 1.56 1.59 1.58 1.49
CSENS+CSPEC:Opt 1.76
CPPV:Kmeans 0.363 0.503 0.762 0.788 .809
CPPV:HC 0.362 0.49 0.712 0.766 .805
CPPV:MB 0.323 0.413 0.531 0.634 .699
CPPV:Opt 0.808
CNPV:Kmeans 0.964 0.953 0.943 0.905 .874
CNPV:HC 0.977 0.964 0.943 0.915 .883
CNPV:MB 0.972 0.955 0.933 0.917 .893
CNPV:Opt 0.952
CPPV+CNPV:Kmeans 1.33 1.46 1.71 1.69 1.68
CPPV+CNPV:HC 1.34 1.45 1.65 1.68 1.69
CPPV+CNPV:MB 1.29 1.37 1.46 1.55 1.59
CPPV+CNPV:Opt 1.76
All of these examples are of mostly academic interest to the researchers who use clustering
algorithms since univariate clustering very rarely takes place. We now calculate the indices on a
pair of real data sets. The first dataset contains gene expression data for 5565 genes from 103
samples. These samples are made up of 26 breast cancer, 23 colon cancer, 28 lung cancer and 26
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Figure 5.1: Cluster Sensitivity plus Cluster Specificity for the mixed tumor dataset.
prostate cancer samples. The data collection is described in a paper by (Hoshida et al., 2007) and
the data can be obtained at http://www.broadinstitute.org/cgi-bin/cancer/datasets.cgi . This
should be representative of a relatively easy clustering problem since the samples being compared
are from completely distinct cancer types. To clarify, we expect this problem to be easy relative
to the task of discovering tumor subtypes. The complete tables for the indices can be found in
Appendix C.2. Figure 5.1 shows sensitivity plus specificity for various methods and specifications
of K.
There are three obvious lessons in this plot. First, the performance bump that we saw when
K = G in the univariate setting does not appear to exist with this real data as none of the
methods show a convincing improvement in performance at the correct number of subgroups.
The second clear message is that the selection of the linkage function in a hierarchical clustering
algorithm can have a substantial impact on the algorithms performance. Finally the sudden jump
in performance at K = 7, for HC with Average and Single Linkage, is worth examining. The
distribution of clustering assignments for K = 6, 7 and 8 are shown in Figure 5.7, Figure 5.8 and
Figure 5.9 respectively. These tables suggest that in the high dimensional setting of real data,
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Table 5.7: Contingency table of cluster assignments for the Mixed Tumor Data when K = 6
Pathology/Cluster 1 2 3 4 5 6
Breast 23 1 1 1 0 0
Colon 23 0 0 0 0 0
Lung 22 0 0 0 1 5
Prostate 25 1 0 0 0 0
Table 5.8: Contingency table of cluster assignments for the Mixed Tumor Data when K = 7
Pathology/Cluster 1 2 3 4 5 6 7
Breast 21 1 1 2 1 0 0
Colon 0 0 0 23 0 0 0
Lung 22 0 0 0 0 1 5
Prostate 0 1 0 25 0 0 0
Hierarchical clustering methods are very sensitive to outliers, often grouping them into distinct
clusters. For this reason we see a pathological behavior where Hierarchical Clustering performs
best when K is grossly misspecified, forcing the outliers into larger groups.
We now turn to the more difficult problem of using clustering algorithms to identify subtypes
of lung cancer. The next dataset is described as dataset A in a paper by Bhattacharjee et al.
(2001), and it was also analyzed in a paper by Thalamuthu et al. (2006). The data can be found
at http://www.pnas.org/content/98/24/13790/suppl/DC1 The data contains 203 lung samples,
( 127 adenocarcinomas, 21 squamous cell carcinomas, 20 pulmonary carcinoids, 6 small cell lung
cancers and 17 normal lung specimens ) categorized by histology. The full table of clustering
indices are provided in Appendix C.2. As expected, Figure 5.2, shows an overall drop in perfor-
mance relative to the mixed tumor example. We also once again see that the selection of a linkage
function has a powerful impact on algorithm performance and once again no boost in performance
is observed when K = G. It should also be noted that the order of algorithmic performance has
changed. When analyzing the mixed tumor data, Kmeans was clearly the best algorithm while
Table 5.9: Contingency table of cluster assignments for the Mixed Tumor Data when K = 8
Pathology/Cluster 1 2 3 4 5 6 7 8
Breast 21 1 1 2 1 0 0 0
Colon 0 0 0 23 0 0 0 0
Lung 22 0 0 0 0 0 1 5
Prostate 0 1 0 0 0 25 0 0
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Figure 5.2: Cluster Sensitivity plus Cluster Specificity for the Lung Cancer dataset.
hierarchical clustering with single and average linkage performed terribly. For the lung cancer
data, average linkage hierarchical clustering demonstrated the best performance at all values of
K. Unfortunately, we can offer no theory that would allow a researcher to anticipate the relative
performance of these methods a priori.
5.6 Discussion
We have demonstrated the differences between clustering, classification and linkage detection.
We have introduced new indices of clustering performance, which put the problem of clustering
validation into the well understood framework of sensitivity and specificity. Our theoretical anal-
ysis along with the examination of index performance on real and simulated data has provided
a number of important lessons for researchers interested in both using and developing clustering
algorithms. For researchers who seek to improve clustering algorithms it is important to realize
the differences between clustering classification and linkage detection. Many iterative clustering
algorithms that utilize optimal classification rules could conceivably be improved by instead im-
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plementing optimal clustering rules. For users of clustering algorithms the use of clustering indices
with clear probabilistic interpretations can be used to improve the interpretation of clustering
results. For example, we showed that even in some relatively simple settings pairs of samples
were being grouped together when they should not be about 25% of the time. This suggests
that, in the biomedical field, it would be unwise to think of clustering labels as some sort of
newly discovered ‘true’ classification. This limitation can be seen even in the absence of problems
with algorithm selection, variable reduction and estimation of G, all of which undoubtedly make
clustering results more difficult to interpret. Researchers should be aware that the selection of
different clustering algorithms can have powerful impacts on the results observed. Furthermore,
we have seen that optimal algorithm performance can theoretically occur when K 6= G and in
practice performance may not improve the slightest bit when K = G. Thus, validation methods
that rely on this principle are likely to be misguided. Our indices, and all of the others we are
familiar with, are based on pairwise linkage and we have shown that optimal pairwise linkage
does not necessarily correspond to optimal clustering. This suggests that there could be circum-
stances under which indices based on pairwise comparisons would not be ideal. Nonetheless, for
most purposes we have proposed an effective way to not only compare clustering methods but
also to improve the way researchers interpret clustering results. Testing an algorithm on similar
supervised settings with our indices can help researchers find an appropriate level of confidence
to ascribe the results of their clustering algorithms. For the settings that we examined, it would
be foolish to think of cluster assignments as an approximation for subtype discovery. The reality
is that different algorithms yield vastly different partitions and even in the best case scenarios
elements from different subtypes will frequently be grouped with elements from different com-
ponents and vice versa. This is not to say that the clustering algorithms are useless. We are
grouping together elements according to some sort of defined distance metric which could con-
ceivably be valuable for many different reasons. We simply observe that it is easy to construct
examples where important subtypes exist and clustering algorithms should not be expected to
discover those subtypes with any sort of reliability. It is our hope that model based approach that
we have provided, along with our probabilistic indices, will help researchers better understand
and interpret the results of clustering algorithms on their data.
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CHAPTER 6: FUTURE WORK
Mass spectrometry proteomics experiments pose interesting and unique problems for statisti-
cal modeling. In this thesis, progress has been made by establishing formal models that account
for missing data biases which are for the most part currently being ignored by the scientific com-
munity. The most obvious need for further work would be the development software tools to
implement these methods. To this regard some theoretical work will need to be done to obtain
model estimates in a practical amount of time. In all of our work we have used small sets of
data to establish principles but in the real world scientists are working with ever larger datasets.
A lot of work would need to be done to make the Bayesian solutions proposed feasible for real
world studies. In addition to these pragmatic developments, much work still needs to be done to
explore the complexities posed by the general discovery mass spectrometry experiment. We have
established new ways to categorize missing data, but it remains unclear which levels of missing
data under what circumstances can actually be useful. There is also work that needs to be done
regarding reference selection in large experiments. It is not known a priori which contrasts in
these experiments will be estimable. In the Bayesian model this will be reflected in the variance,
however in order for this to be discovered contrasts need to be taken directly from the Gibbs
samples. Attempting to combine summary statistics will not work. In addition to the difficulties
posed by large complex experiments it would be natural to combine the work done on clustering
evaluation and proteomics modeling. It would be very surprising if the missing data biases and
relative nature of mass spectrometry data didn’t have unusual effects on clustering algorithms.
The nature of these effects has yet to be explored.
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APPENDIX A: CHAPTER 3 DETAILS
A.1 Deriving the full conditionals for the M5 model
f(Yijk|·)(yn) =
∏N
k=n1+1
(1− Φ(a+ byk))
∏n1
k=1 Φ(a+ byk)fYi∫ ∏N
k=n1+1
(1− Φ(a+ byk))
∏n1
k=1 Φ(a+ byk)fYidy
=
(1− Φ(a+ byn))fYi∫
(1− Φ(a+ byn))fYidy
=
Φ(−a− byn) exp(− 12σ (yn − αn(i) ± µi2 )2)∫
Φ(a− byn) exp(− 12σ (yn − αn(i) ± µi2 )2)dy
∝ Φ(−a− byn) exp(− 1
2σ
(yn − αn(i) ±
µi
2
)2)
Which is the kernel of an extended skew normal distribution defined as
fskew(x) =
φ(x−µxσx )Φ(ω
√
1 + c2 + c(x−µxσx ))
σxΦ(ω)
where
µx = αn(i) ±
µi
2
, σx =
√
σ
and
Φ(−a− byn) = Φ(−a− σx
σx
b(yn − µx + µx)) = Φ(−a− σxb(yn − µx
σx
)− bµx)
Thus,
−bσx = c, ω
√
1 + c2 = −a− bµx
⇒ ω = −a− bµx√
1 + σb2
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Therefore,
f(Yijk|µi,αj(i),Yijk′ ,θ,R)(x) =
φ(x−µx√
σ
)Φ(ω
√
1 + (−b√σ)2 − b√σ(x−µx√
σ
))
√
σΦ(ω)
=
φ(x−µx√
σ
)Φ(−a− bx)
√
σΦ(ω)
.
Similarly
f(µi|·) ∝ fY|µi,αfµi
∝ exp(− 1
2τ
(µi − βµ)2)
mi∏
j=1
exp
(
− 1
2σ
(
(yij1 − αj(i) −
µi
2
)2 + (yij2 − αj(i) +
µi
2
)2
))
= exp
− 1
2τ
(µi − βµ)2 +
mi∑
j=1
− 1
2σ
(
(yij1 − αj(i) −
µi
2
)2 + (yij2 − αj(i) +
µi
2
)2
)
= exp
−1
2
1
τ
µ2i −
2βµ
τ
µi +
1
σ
mi∑
j=1
1
2
µ2i − µi(yij1 − αj(i)) + µi(yij2 − αj(i))
+ C

for some constant C.
∝ exp
(
−1
2
(
µ2i (
1
τ
+
mi
2σ
)− µi
(
2βµ
τ
+
1
σ
∑
(yij1 − yij2)
)))
= exp
(
− 1
2( 2στ2σ+miτ )
(
µ2i − µi
2στ
2σ +miτ
(
2βµ
τ
+
1
σ
∑
(yij1 − yij2)
)))
= exp
(
− 1
2( 2στ2σ+miτ )
(
µ2i − µi(
2βµσ + τ
∑
(yij1 − yij2)
σ + miτ2
)
))
∝ exp
(
− 1
2( 2στ2σ+miτ )
(
µi − (
βµσ +
τ
2
∑
(yij1 − yij2)
σ + miτ2
)
)2)
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Therefore,
(µi|αi,Y, θ,R) ∼ N
(
βµσ +
τ
2
∑
j (yij1 − yij2)
σ + miτ2
,
στ
σ + miτ2
)
.
The distribution for α given everything else can be derived in a similar manner.
f(αj(i)|·) ∝ fY|µi,αfαj(i)
= exp(− 1
2ξ
(µi − βα)2) exp
(
− 1
2σ
(
(yi,j,1 − αj(i) −
µi
2
)2 + (yij2 − αj(i) +
µi
2
)2
))
= exp(−1
2
(
1
ξ
(α2j(i) − 2βααj(i))+
1
σ
(
2α2j(i) − 2αj(i)(yij1 −
µi
2
)− 2αj(i)(yij2 +
µi
2
)
)
) + C)
for some constant C
∝ exp(−1
2
(
1
ξ
(α2j(i) − 2βααj(i)) +
2
σ
(
α2j(i) − αj(i)(yij1 + yij2)
)
))
= exp(−1
2
(α2j(i)(
1
ξ
+
2
σ
)− αj(i)(
2βα
ξ
+ 2
yij1 + yij2
σ
)))
= exp(− 1
2 ξσσ+2ξ
(α2j(i) − αj(i)
ξσ
σ + 2ξ
(
2βα
ξ
+ 2
yij1 + yij2
σ
)))
= exp(− 1
2 ξσσ+2ξ
(α2j(i) − αj(i)(
2βασ + 2ξ(yij1 + yij2)
σ + 2ξ
)))
= exp(− 1
2 ξσσ+2ξ
(αj(i) − (
βασ + ξ(yij1 + yij2)
σ + 2ξ
))2)
Therefore,
(αj(i)|·) ∼ N
(
βασ + ξ(yij1 + yij2)
σ + 2ξ
,
ξσ
σ + 2ξ
)
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APPENDIX B: CHAPTER 4 DETAILS
B.1 Deriving a general full conditional distribution for the normal parameters
Each of the parameters relating to the mean model have a similar structure and the full
conditional distribution is given by one generalized formula.
Let α represent any of the mean parameters with a Gaussian prior. Let βα, τ be the mean
and variance of α and let Xθ∗ be the product of the design matrix and parameter vector with
α removed from θ and the column X[·,α] removed from X. Here the subscript [·, α] is used
to reference a sub-matrix of X. α indicates a single column, the one corresponding to the α
parameter, and the · indicates that all of the rows are included. Finally, let i, · · · , I represent the
row indices for which X[·,α] = 1. Then
f(α|·) ∝ f(Y|·)fα
∝ exp
(
− 1
2τ
(α− βα)2 − 1
2σ
(
(yi − α−Xθ∗[i])2
)− · · · − 1
2σ
(yI − α−Xθ∗[I])2
)
∝ exp
− 1
2τ
(α2 − 2αβα)− 1
2σ
I∑
j=i
(
α2 − 2α(yj −Xθ∗[j])
)
= exp
(
−1
2
(
α2
(
1
τ
+
I
σ
)
− α
(
2βα
τ
+
2
∑I
j=i(yj −Xθ∗[j])
σ
)))
= exp
− 1
2τσ/(σ + τI)
α2 − 2α
σ + τI
σβα + τ I∑
j=i
(yj −Xθ∗[j])

∝ exp
− 1
2τσ/(σ + τI)
(
α− σβα + τ
∑I
j=i(yj −Xθ∗[j])
σ + τI
)2
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Therefore,
(α|·) ∼ N
(
σβα + τ
∑I
j=i(yj −Xθ∗[j])
σ + τI
,
τσ
σ + τI
)
B.2 Deriving the full conditional distribution for a level 2 missing value in an
iTRAQ experiment
In a K-plex iTRAQ experiment we expect that either a peptide will be observed in K samples
or none for a given run. If Ym is a missing intensity then Let Yi, ..., Yn represent the intensities
from the same run for the same peptide as Ym. Then,
f(Ym|·)(ym) ∝ (1− Φ
a+ b(ym + n∑
j=i
yj)
) exp(− 1
2σ
(ym −Xθ[m])2)
= Φ
ym(−b)− a− b n∑
j=i
yj
 exp(− 1
2σ
(ym −Xθ[m])2)
Which is the kernel of an extended skew normal distribution defined as
fskew(x) =
φ(x−µxσx )Φ(ω
√
1 + c2 + c(x−µxσx ))
σxΦ(ω)
Where
µx = Xθ[m], σx =
√
σ
and
Φ
ym(−b)− a− b n∑
j=i
yj
 = Φ
−bσx
σx
(ym − µx + µx)− a− b
n∑
j=i
yj

= Φ
−bσx (ym − µx)
σx
− bµx − a− b
n∑
j=i
yj

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Thus,
−bσx = c, ω
√
1 + c2 = −bµx − a− b
n∑
j=i
yj
⇒ ω = −a− b
∑n
j=i yj − bµx√
1 + σb2
Therefore,
f(Ym|·)(x) =
φ(x−µx√
σ
)Φ(ω
√
1 + (−b√σ)2 − b√σ(x−µx√
σ
))
√
σΦ(ω)
=
φ(x−µx√
σ
)Φ(−a− b∑nj=i yj − bx)√
σΦ(ω)
.
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APPENDIX C: CHAPTER 5 DETAILS
C.1 Proof that optimal classification and clustering are equal when G=2
Claim: For G=2 the partition induced from the optimal classification is equivalent to the
optimal partition.
Proof by induction.
Atomic Case: n = 2. There are two partitions. {1, 2} and {{1}, {2}}
p(1, 2) = pi1,1pi2,1 + pi1,2pi2,2
p(1, 2) = pi1,1pi2,2 + pi1,2pi2,1
Let pii,U = max(pii,1, pii,2) and pii,L = min(pii,1, pii,2)
Then
pi1,Upi2,U + pi1,Lpi2,L − (pi1,Upi2,L + pi1,Lpi2,U )
= pi1,U (pi2,U − pi2,L) + pi1,L(pi2,L − pi2,U )
= (pi1,U − pi1,L)(pi2,U − pi2,L) > 0
Thus pi1,Upi2,U + pi1,Lpi2,L > pi1,Upi2,L + pi1,Lpi2,U and whichever partition corresponds to the prob-
ability pi1,Upi2,U +pi1,Lpi2,L is the optimal partition. But pi1,Upi2,U is the probability of the optimal
cluster assignment. Thus when G=2 the partition induced by the optimal classification is the
optimal partition.
Induction Step: For n data points the optimal partition equals the clustering induced by the
optimal classifier.
Once again the probability of any partition can be written as the sum of the two classifica-
tion probabilities which generate the partition. So for n+1 points let the optimal partition be
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pi1,x1 . . . pin,xnpin+1,U + pi1,x′1 . . . pin,x′npin+1,L, where x
′ is always the opposite assignment of x.
Consider
pi1,U . . . pin,Upin+1,U + pi1,L . . . pin,Lpin+1,L − (pi1,x1 . . . pin,xnpin+1,U + pi1,x′1 . . . pin,x′npin+1,L)
= pin+1,U (pi1,U . . . pin,U − pi1,x1 . . . pin,xn)− pin+1,L(pi1,x′1 . . . pin,x′n − pi1,L . . . pin,L)
By the induction assumption we know that
pi1,U . . . pin,U + pi1,L . . . pin,L ≥ pi1,x1 . . . pin,xn + pi1,x′1 . . . pin,x′n
⇒ pi1,U . . . pin,U − pi1,x1 . . . pin,xn ≥ pi1,x′1 . . . pin,x′n − pi1,L . . . pin,L
So
= pin+1,U (pi1,U . . . pin,U − pi1,x1 . . . pin,xn)− pin+1,L(pi1,x′1 . . . pin,x′n − pi1,L . . . pin,L)
> pin+1,U (pi1,x′1 . . . pin,x′n − pi1,L . . . pin,L)− pin+1,L(pi1,x′1 . . . pin,x′n − pi1,L . . . pin,L)
= (pin+1,U − pin+1,L)(pi1,x′1 . . . pin,x′n − pi1,L . . . pin,L) > 0
Thus the probability of the optimal partition for n+1 points is given by
pi1,U . . . pin,Upin+1,U + pi1,L . . . pin,Lpin+1,L
which is the probability for the partition generated by the optimal cluster since is contains the
term pi1,U . . . pin,Upin+1,U .
By induction, when G=2 the optimal partition is equivalent to the partition induced by the
optimal cluster.
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C.2 Tables
C.2.1 Example 1
> kappa_table (1, pi1, delta)
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
0 1 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1
0.1 1 0.998 0.996 0.995 0.994 0.994 0.994 0.995 0.996 0.998 1
0.2 1 0.989 0.981 0.975 0.972 0.971 0.972 0.975 0.981 0.989 1
0.3 1 0.972 0.950 0.935 0.926 0.922 0.926 0.935 0.950 0.972 1
0.4 1 0.945 0.902 0.871 0.852 0.846 0.852 0.871 0.902 0.945 1
0.5 1 0.910 0.840 0.790 0.760 0.750 0.760 0.790 0.840 0.910 1
> kappa_table (2, pi1, delta)
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
0 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
0.1 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
0.2 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
0.3 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
0.4 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
0.5 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
> kappa_table (3, pi1, delta)
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
0 1.00 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1
0.1 0.82 0.835 0.850 0.866 0.883 0.901 0.919 0.938 0.958 0.978 1
0.2 0.68 0.700 0.723 0.748 0.775 0.805 0.838 0.874 0.912 0.955 1
0.3 0.58 0.599 0.621 0.648 0.681 0.718 0.762 0.811 0.868 0.931 1
0.4 0.52 0.532 0.550 0.574 0.606 0.647 0.698 0.759 0.830 0.911 1
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Table 6.1: CSENS for Mixed Tumor Data
K=2 K=3 K=4 K=5 K=6 K=7 k=8
K-Means 0.98 0.943 0.802 0.749 0.724 0.646 0.625
Average Linkage HC 0.98 0.959 0.874 0.835 0.817 0.785 0.785
Single Linkage HC 0.98 0.959 0.941 0.884 0.85 0.85 0.834
Complete Linkage HC 0.946 0.843 0.826 0.756 0.752 0.653 0.653
Table 6.2: CSPEC for Mixed Tumor Data
K=2 K=3 K=4 K=5 K=6 K=7 k=8
K-Means 0.51 0.813 0.873 0.951 0.963 0.977 0.988
Average Linkage HC 0.019 0.038 0.131 0.166 0.184 0.715 0.872
Single Linkage HC 0.019 0.038 0.057 0.112 0.149 0.601 0.613
Complete Linkage HC 0.65 0.685 0.691 0.727 0.727 0.808 0.947
0.5 0.50 0.503 0.512 0.530 0.559 0.600 0.655 0.725 0.808 0.901 1
> kappa_table (4, pi1, delta)
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
0 1.0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1
0.1 0.9 0.909 0.918 0.928 0.938 0.947 0.957 0.968 0.978 0.989 1
0.2 0.8 0.816 0.833 0.851 0.870 0.889 0.909 0.930 0.952 0.976 1
0.3 0.7 0.722 0.745 0.769 0.795 0.824 0.854 0.886 0.921 0.959 1
0.4 0.6 0.625 0.652 0.682 0.714 0.750 0.789 0.833 0.882 0.938 1
0.5 0.5 0.526 0.556 0.588 0.625 0.667 0.714 0.769 0.833 0.909 1
Table 6.3: CSENS+CSPEC for mixed tumor data
K=2 K=3 K=4 K=5 K=6 K=7 k=8
K-Means 1.49 1.76 1.68 1.7 1.69 1.62 1.61
Average Linkage HC 1 0.997 1 1 1 1.5 1.66
Single Linkage HC 1 0.997 0.998 0.997 0.999 1.45 1.45
Complete Linkage HC 1.6 1.53 1.52 1.48 1.48 1.46 1.6
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Table 6.4: CPPV for mixed tumor data
K=2 K=3 K=4 K=5 K=6 K=7 k=8
K-Means 0.402 0.628 0.68 0.837 0.867 0.903 0.947
Average Linkage HC 0.251 0.251 0.252 0.252 0.251 0.48 0.673
Single Linkage HC 0.251 0.251 0.251 0.251 0.251 0.417 0.419
Complete Linkage HC 0.476 0.473 0.472 0.482 0.48 0.533 0.806
Table 6.5: CNPV for mixed tumor data
K=2 K=3 K=4 K=5 K=6 K=7 k=8
K-Means 0.987 0.977 0.929 0.919 0.912 0.892 0.887
Average Linkage HC 0.748 0.736 0.756 0.75 0.75 0.908 0.923
Single Linkage HC 0.748 0.736 0.742 0.743 0.748 0.923 0.917
Complete Linkage HC 0.973 0.929 0.922 0.899 0.897 0.874 0.891
C.2.2 Mixed Tumor Data
C.2.3 Lung Cancer Subtype Data
Table 6.6: CPPV+CNPV for mixed tumor data
K=2 K=3 K=4 K=5 K=6 K=7 k=8
K-Means 1.39 1.61 1.61 1.76 1.78 1.8 1.83
Average Linkage HC 0.999 0.987 1.01 1 1 1.39 1.6
Single Linkage HC 0.999 0.987 0.992 0.994 0.999 1.34 1.34
Complete Linkage HC 1.45 1.4 1.39 1.38 1.38 1.41 1.7
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Table 6.7: CSENS for lung cancer data
K=2 K=3 K=4 K=5 K=6 K=7 k=8
K-Means 0.998 0.511 0.425 0.365 0.379 0.37 0.263
Average Linkage HC 1 0.986 0.984 0.975 0.962 0.948 0.947
Single Linkage HC 0.998 0.996 0.983 0.969 0.968 0.96 0.96
Complete Linkage HC 0.93 0.651 0.424 0.414 0.264 0.264 0.259
Table 6.8: CSPEC for lung cancer data
K=2 K=3 K=4 K=5 K=6 K=7 k=8
K-Means 0.351 0.682 0.81 0.876 0.94 0.941 0.957
Average Linkage HC 0.368 0.373 0.373 0.373 0.378 0.382 0.382
Single Linkage HC 0.018 0.035 0.041 0.047 0.065 0.205 0.362
Complete Linkage HC 0.404 0.688 0.839 0.845 0.87 0.878 0.92
Table 6.9: CSENS+CSPEC for lung cancer data
K=2 K=3 K=4 K=5 K=6 K=7 k=8
K-Means 1.35 1.19 1.23 1.24 1.32 1.31 1.22
Average Linkage HC 1.37 1.36 1.36 1.35 1.34 1.33 1.33
Single Linkage HC 1.02 1.03 1.02 1.02 1.03 1.16 1.32
Complete Linkage HC 1.33 1.34 1.26 1.26 1.13 1.14 1.18
Table 6.10: CPPV for lung cancer data
K=2 K=3 K=4 K=5 K=6 K=7 k=8
K-Means 0.603 0.614 0.688 0.744 0.862 0.862 0.858
Average Linkage HC 0.61 0.608 0.608 0.606 0.604 0.603 0.602
Single Linkage HC 0.501 0.505 0.503 0.501 0.506 0.544 0.598
Complete Linkage HC 0.607 0.673 0.722 0.726 0.667 0.682 0.761
Table 6.11: CNPV for lung cancer data
K=2 K=3 K=4 K=5 K=6 K=7 k=8
K-Means 0.993 0.585 0.587 0.582 0.605 0.602 0.568
Average Linkage HC 0.999 0.964 0.959 0.939 0.909 0.882 0.879
Single Linkage HC 0.905 0.907 0.708 0.609 0.669 0.84 0.902
Complete Linkage HC 0.853 0.666 0.595 0.593 0.544 0.547 0.557
Table 6.12: CPPV+CNPV for lung cancer data
K=2 K=3 K=4 K=5 K=6 K=7 k=8
K-Means 1.6 1.2 1.28 1.33 1.47 1.46 1.43
Average Linkage HC 1.61 1.57 1.57 1.54 1.51 1.48 1.48
Single Linkage HC 1.41 1.41 1.21 1.11 1.17 1.38 1.5
Complete Linkage HC 1.46 1.34 1.32 1.32 1.21 1.23 1.32
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